<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-id journal-id-type="pmc-domain-id">2873</journal-id><journal-id journal-id-type="pmc-domain">ncomms</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11263583</article-id><article-id pub-id-type="pmcid-ver">PMC11263583.1</article-id><article-id pub-id-type="pmcaid">11263583</article-id><article-id pub-id-type="pmcaiid">11263583</article-id><article-id pub-id-type="pmid">39039045</article-id><article-id pub-id-type="doi">10.1038/s41467-024-49423-6</article-id><article-id pub-id-type="publisher-id">49423</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Protective alleles and precision healthcare in crewed spaceflight</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2123-3949</contrib-id><name name-style="western"><surname>Rutter</surname><given-names initials="LA">Lindsay A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacKay</surname><given-names initials="MJ">Matthew J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4984-0567</contrib-id><name name-style="western"><surname>Cope</surname><given-names initials="H">Henry</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4425-9746</contrib-id><name name-style="western"><surname>Szewczyk</surname><given-names initials="NJ">Nathaniel J.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8733-9925</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="J">JangKeun</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2866-8294</contrib-id><name name-style="western"><surname>Overbey</surname><given-names initials="E">Eliah</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7533-8802</contrib-id><name name-style="western"><surname>Tierney</surname><given-names initials="BT">Braden T.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0276-8000</contrib-id><name name-style="western"><surname>Muratani</surname><given-names initials="M">Masafumi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lamm</surname><given-names initials="B">Ben</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1203-8239</contrib-id><name name-style="western"><surname>Bezdan</surname><given-names initials="D">Daniela</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paul</surname><given-names initials="AM">Amber M.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Schmidt</surname><given-names initials="MA">Michael A.</given-names></name><address><email>mschmidtphd@patternanalysis.org</email></address><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6232-9969</contrib-id><name name-style="western"><surname>Church</surname><given-names initials="GM">George M.</given-names></name><address><email>gc@hms.harvard.edu</email></address><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0738-1574</contrib-id><name name-style="western"><surname>Giacomello</surname><given-names initials="S">Stefania</given-names></name><address><email>stefania.giacomello@scilifelab.se</email></address><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1850-1642</contrib-id><name name-style="western"><surname>Mason</surname><given-names initials="CE">Christopher E.</given-names></name><address><email>chm2042@med.cornell.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02956yf07</institution-id><institution-id institution-id-type="GRID">grid.20515.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2369 4728</institution-id><institution>Transborder Medical Research Center, </institution><institution>University of Tsukuba, </institution></institution-wrap>Ibaraki, 305-8575 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02956yf07</institution-id><institution-id institution-id-type="GRID">grid.20515.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2369 4728</institution-id><institution>Department of Genome Biology, </institution><institution>Institute of Medicine, University of Tsukuba, </institution></institution-wrap>Ibaraki, 305-8575 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02r109517</institution-id><institution-id institution-id-type="GRID">grid.471410.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 7643</institution-id><institution>Department of Physiology and Biophysics, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10065 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02r109517</institution-id><institution-id institution-id-type="GRID">grid.471410.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 7643</institution-id><institution>The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10021 USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02r109517</institution-id><institution-id institution-id-type="GRID">grid.471410.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 7643</institution-id><institution>The WorldQuant Initiative for Quantitative Prediction, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10065 USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ee9ar58</institution-id><institution-id institution-id-type="GRID">grid.4563.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8868</institution-id><institution>School of Medicine, </institution><institution>University of Nottingham, </institution></institution-wrap>Nottingham, DE22 3DT UK </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jr3y717</institution-id><institution-id institution-id-type="GRID">grid.20627.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7841</institution-id><institution>Ohio Musculoskeletal and Neurological Institute (OMNI), Heritage College of Osteopathic Medicine, </institution><institution>Ohio University, </institution></institution-wrap>Athens, OH 45701 USA </aff><aff id="Aff8"><label>8</label>Colossal Biosciences, 1401 Lavaca St, Unit #155 Austin, Austin, TX 78701 USA </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03a1kwz48</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution>Institute of Medical Genetics and Applied Genomics, </institution><institution>University of T&#252;bingen, </institution></institution-wrap>T&#252;bingen, Germany </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03a1kwz48</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution>NGS Competence Center T&#252;bingen (NCCT), </institution><institution>University of T&#252;bingen, </institution></institution-wrap>T&#252;bingen, Germany </aff><aff id="Aff11"><label>11</label>Yuri GmbH, Meckenbeuren, Germany </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/010jskt71</institution-id><institution-id institution-id-type="GRID">grid.255501.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0561 4552</institution-id><institution>Embry-Riddle Aeronautical University, </institution><institution>Department of Human Factors and Behavioral Neurobiology, </institution></institution-wrap>Daytona Beach, FL 32114 USA </aff><aff id="Aff13"><label>13</label>Sovaris Aerospace, Boulder, CO 80302 USA </aff><aff id="Aff14"><label>14</label>Advanced Pattern Analysis &amp; Human Performance Group, Boulder, CO 80302 USA </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.450039.b</institution-id><institution>GC Therapeutics Inc, </institution></institution-wrap>Cambridge, MA 02139 USA </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Genetics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA 02115 USA </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Wyss Institute for Biologically Inspired Engineering, </institution><institution>Harvard University, </institution></institution-wrap>Cambridge, MA 02115 USA </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.5037.1</institution-id><institution-id institution-id-type="ISNI">0000000121581746</institution-id><institution>SciLifeLab, </institution><institution>KTH Royal Institute of Technology, </institution></institution-wrap>Stockholm, 17165 Sweden </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02r109517</institution-id><institution-id institution-id-type="GRID">grid.471410.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 7643</institution-id><institution>The Feil Family Brain and Mind Research Institute, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY 10065 USA </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00vtgdb53</institution-id><institution-id institution-id-type="GRID">grid.8756.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 314X</institution-id><institution>Present Address: School of Chemistry, </institution><institution>University of Glasgow, </institution></institution-wrap>Glasgow, G12 8QQ UK </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">452197</issue-id><elocation-id>6158</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>5</day><month>6</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>23</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-10 13:25:18.197"><day>10</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41467_2024_Article_49423.pdf"/><abstract id="Abs1"><p id="Par1">Common and rare alleles are now being annotated across millions of human genomes, and omics technologies are increasingly being used to develop health and treatment recommendations. However, these alleles have not yet been systematically characterized relative to aerospace medicine. Here, we review published alleles naturally found in human cohorts that have a likely protective effect, which is linked to decreased cancer risk and improved bone, muscular, and cardiovascular health. Although some technical and ethical challenges remain, research into these protective mechanisms could translate into improved nutrition, exercise, and health recommendations for crew members during deep space missions.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">As space travel promises to become a reality for more humans, insights from human genetics could serve to inform space medicine. Here, the authors overview genetic variants that might confer a protective effect in space, and ethical and technical challenges to translating these findings.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Rare variants</kwd><kwd>Personalized medicine</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Humankind has entered a new chapter of deep space exploration, with numerous institutions worldwide publicly aspiring toward a sustainable human presence on the Moon and Mars, which is also broadening the diversity of humans in space. In the past two years, the first person with a prosthetic leg entered space (Inspiration4), and the first person with a physical disability was selected for professional astronaut training by the European Space Agency (ESA). The next few years of spaceflight also feature planned missions to the circumlunar environment after a half-century hiatus, including the first crewed commercial lunar flyby (a team of artists and civilians for the dearMoon project), further broadening the range of people going into space. Moreover, while a steady increase in female space explorers began in 1982, the first mission to land the first woman and person of color on the Moon will finally occur in the Artemis III mission (Fig.&#160;<xref rid="Fig1" ref-type="fig">1A</xref>), coincident with a broadening of the age ranges (Fig.&#160;<xref rid="Fig1" ref-type="fig">1B</xref>) and mission durations (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C) of the astronauts.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Increasing time and breadth of astronauts.</title><p><bold>A</bold> The cumulative number of astronauts who have been in space, plotted by the year of their first mission. <bold>B</bold> Boxplots representing the age of astronauts on their first mission plotted by the decade of their first mission. <bold>C</bold> Boxplots representing the cumulative amount of time an astronaut spent in space plotted against the number of missions in which they have participated. Blue signifies male and pink signifies female astronauts in all plots. Data was scraped from supercluster.com on September 20th, 2021. Only astronauts who spent time in space and crossed the K&#225;rm&#225;n line are displayed.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e495" position="float" orientation="portrait" xlink:href="41467_2024_49423_Fig1_HTML.jpg"/></fig></p><p id="Par4">Of note, only 24 humans have voyaged into the more hazardous conditions outside low-Earth orbit (LEO), all during the Apollo program. The longest Apollo mission lasted only 12 days, and all adventurers were white men between ages 35 and 47, all of whom had passed rigorous physical fitness tests. Consequently, the objective of sending humankind to unexplored horizons over unmatched timescales evokes critical questions about how the human body will respond to new extremes, as well as how to best protect the health of the broader space-faring population. In the coming decades, public and professional space explorers will likely embark on multi-year missions to the Moon and Mars, and this can lead to a more equitable vision of crewed space exploration. Specifically, the space community can democratize vital aspects of spaceflight, ranging from tailored space suit designs, precision health recommendations, and customized countermeasures<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Risks for these crews include radiation-induced cancers, space-induced osteopenia, challenges with pregnancy and child development, and changes for human bodies in Martian- and Lunar-based communities.</p><p id="Par5">The same motivations that drive precision healthcare on Earth could be useful for these new populations in space, where molecular data could be employed to guide therapy and mission recommendations. Multipronged countermeasures that are both environmental (such as advanced spacesuits, spacecrafts, and space habitats) and biomedical (such as omics-based nutrition, exercise, and lifestyle recommendations) likely represent the best contenders to optimize health across a more inclusive gamut of humanity in space. In this paper, we highlight omics technologies as one potential component toward improving prospective health countermeasures in space<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>.</p><p id="Par6">Omics modeling tools assess multiple biological responses (including genomics, epigenomics, transcriptomics, epitranscriptomics, metagenomics, metatranscriptomics, metabolomics, and proteomics) that can converge into useful solutions for mitigating spaceflight-induced physiological deconditioning. Indeed, omics-based recommendations can be integrated alongside other countermeasures to sustain human health in space, and near real-time health monitoring in space could also one day incorporate omics<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. We review an example set of published alleles that appear to be linked to health-protective effects, with relevance both on Earth and in space. Basic research into the protective mechanisms of such alleles may translate into improved therapeutic compound discovery and better-informed nutrition, exercise, and lifestyle recommendations, not only for space explorers, but also for those who work in challenging conditions on Earth. We conclude by discussing some of the significant scientific and ethical challenges related to these themes.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p id="Par7">Growing evidence indicates that spaceflight can elicit a range of stressful and adaptive physiological responses on the human body. Environmental harms like radiation, microgravity, and altered gas composition can jeopardize the health of the musculoskeletal, cardiovascular, digestive, nervous, integumentary, and immune systems; increase the risk of cancer, diabetes, and aging traits; and disrupt vision, sleep cycles, and cognitive behavior<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. There are a range of known alleles across various health-risk categories (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, Supplementary Data&#160;<xref rid="MOESM2" ref-type="media">1</xref>) that may warrant effective and precision countermeasures to improve the physical fitness of both spaceflight participants and terrestrial humans.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Spaceflight health risk countermeasures.</title><p>Examples of health-risk categories that warrant precision countermeasures to improve the physical fitness of both spaceflight participants and terrestrial humankind. From left to right: examples of common spaceflight ailments related to the health-risk category; examples of spaceflight countermeasures related to the health-risk category; examples of terrestrial populations that could benefit from improved precision countermeasures related to the health-risk category. Created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e538" position="float" orientation="portrait" xlink:href="41467_2024_49423_Fig2_HTML.jpg"/></fig></p><p id="Par8">The human health challenges of crewed LEO, cis-lunar, and interplanetary missions will benefit from the development of countermeasures for optimal crew health and safety, especially for known genes that could confer a strong impact on spaceflight-related risks. Examples of known genes relevant for spaceflight include those related to altered radiation tolerance (<italic toggle="yes">TP53</italic>), hematopoiesis (<italic toggle="yes">EPOR</italic>), bone density (<italic toggle="yes">LRP5</italic>), and immune function (HLA alleles and cytokines)<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, although there may be upper limits for adaptation<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. As such, even when the mechanism of a phenotype is known, natural evolution with extant alleles may have a limited range for adaptation. Nonetheless, an important role of omics (and other omics modeling, such as organoids)<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup> is to understand risks and mechanisms at a deeper level, so that traditional protective measures (such as spacesuits, exercise equipment, and radiation shielding) can be designed in more informed ways. As a result, comprehensive aerospace healthcare programs in the future would likely integrate both omics information and traditional protective measures. We briefly illustrate this below by focusing on key examples of radiation-induced cancer and space-induced bone demineralization.</p><sec id="Sec3"><title>Example 1: Space-induced radiation syndrome and cancer threat</title><p id="Par9">Radiation exposure is one of the predominant health hazards of deep space missions, for both in-flight and long-term, post-flight risks. In-flight concerns include acute radiation sickness (ARS), which may include hair loss, cataracts, metabolic deficiency, and gastrointestinal dysfunction<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>; central nervous system (CNS) disturbances that may affect cognitive abilities, motor functions, and behavioral performance<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>; and degeneration of radiation-sensitive immunological tissues that could weaken the immune system<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. One prominent long-term issue is the risk of fatal cancer from radiation exposure<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. For context, over the course of one year, the typical human is exposed to approximately 3 milliSieverts (mSv) on Earth versus 144&#8201;mSv on the International Space Station (ISS)<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>, in addition to varied doses and types of ionizing radiation (IR).</p><p id="Par10">Astronauts on the ISS, which is located in LEO, are exposed to IR but are mostly protected by Earth&#8217;s magnetosphere. In contrast, future deep space missions outside of LEO will expose astronauts to increased doses of radiation, with a higher flux of galactic cosmic rays (GCRs)<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. For example, a single 500-day mission to Mars would likely expose astronauts to 1000&#8201;mSv, the career limit set by international space agencies, which corresponds to a 3% increased risk of lethality from exposure-induced cancer<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Recent studies that incorporated non-targeted radiation effects estimate that cancer risks from Mars missions may be higher than previously estimated<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. It is worth noting that other celestial bodies that have been nominated for far-future human exploration may be even more dangerous: One example is Europa, which receives more than 5000&#8201;mSv of radiation each day, enough to prove deadly to humans<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par11">Current radiation countermeasures include nutrition, drugs, and anti-radiation spacecraft shielding, but these offer only partial protection<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. Moreover, there are currently no FDA-approved radioprotectants that can be deployed for crews, although cytokine supplementation therapy (Neupogen, Neulasta, and Leukine) has been approved by the FDA for the treatment of the acute hematopoietic syndrome. Other possible radiation countermeasures could include radiation absorbers and nutrition (scavenger vitamins, trace elements, and minerals) (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. In addition, individual susceptibility to radiation-induced cancer may be a key factor<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>, with individual differences observed even in early studies of radiation victims<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and radiosensitivity appears to be influenced by a variety of factors. These factors include known susceptibility genes (such as BReast CAncer gene (BRCA) 1 and 2 mutations), age, sex, nutrition, toxin exposure, comorbidities, inflammatory state, and viral infections<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. At this time, the National Aeronautics and Space Administration (NASA) predicts individual risk for carcinogenesis based on statistics at the population level, and genomics and other omics data could better inform these estimates<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Such omics-based information for spaceflight could also be relevant for soldiers, emergency first responders, coal miners, radiologic technicians, reactor workers, pilots, and others who enter radioactive environments (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p></sec><sec id="Sec4"><title>Example 2: Space-induced bone demineralization</title><p id="Par12">Observations within the limited setting of LEO suggest an average bone mineral density (BMD) loss of 1&#8211;1.5% each month for weight-bearing bones<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. Six-month missions on the ISS reportedly induce bone loss equivalent to two decades of aging, some of which may be long-lasting<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>; this finding has implications about missions that will last more than one year on the ISS, the Moon, and Mars. Multiyear missions, especially ones that journey outside of LEO, are harder to model, due to the absence of any comparable data. However, recent models estimate astronauts may suffer 32.4&#8211;36.8% BMD loss during missions to Mars, with up to 100% developing osteopenia, 33% developing osteoporosis, and 79% reaching fracture risk levels that NASA deems impermissible<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. These models were developed using astronaut data inside LEO<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, which is a critical limitation; deep space radiation is hypothesized to exacerbate the BMD loss already caused by microgravity unloading<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. For example, cancer patients routinely experience increased bone fracture risk in areas irradiated during treatment<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Hence, the severity of bone damage during interplanetary missions may be even higher, once taking into account the factor of deep space radiation and calcium loss. Bone healing could also be impaired due to microgravity, where sepsis and thromboembolic blood clots could ultimately present<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Moreover, even though BMD loss has been shown to partially recover one year after spaceflight, recovered bone appeared to be deposited into bone architecture similar to that of older people<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, indicating the recovery is incomplete.</p><p id="Par13">With several upcoming human missions into deep space (e.g. Artemis II, III, dearMoon, and Mars missions), we will better understand the nature of space-induced bone demineralization. Those data could likely improve countermeasures and the incorporation of exercise, pharmacology, and nutrition protocols (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). For example, the Advanced Resistive Exercise Device (ARED) improves the health of astronauts by reducing the magnitude of common space health ailments, including BMD decreases<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, isokinetic strength decreases<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, and immune system dysregulation<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. The ARED may confer more pronounced physiological benefits than its predecessor, the interim Resistive Exercise Device (iRED), which only offered resistance exercise at lower quality and quantity loads. Unfortunately, current exercise spaceflight devices may not practically be deployed in upcoming deep space vessels due to limited cargo volume. As such, flight exercise hardware may need to be scaled down for compatibility, and the feasibility of next-generation miniaturized equipment (such as the Miniature Exercise Device-2 (MED-2)) is currently being assessed<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p><p id="Par14">Vitamin D is another key mediator of bone health through calcium absorption and bone mineralization, and represents a relevant target for upcoming missions. Prior to 2006, crews supplemented with ~400 International Units (IU) of vitamin D each day during 3&#8211;6 months missions still showed decreases in vitamin D status postflight<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. When ground-based studies in Antarctica and Johnson Space Center verified that daily vitamin D doses of 800&#8211;2000 IU were safe and could maintain vitamin D status for 3&#8211;6 months in settings devoid of ultraviolet (UV) light exposure, vitamin D supplementation recommendations for space crew in similar missions were increased in 2006 from daily doses of 400 to 800 IU<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Despite such evidence-based improvements in dietary and exercise countermeasures, BMD loss remains an unsolved health hazard in spaceflight that will likely be more problematic for future long-term missions. Here again, omics data analysis could potentially further discover and improve countermeasures. While current equations that predict BMD loss consider population-level differences with factors of ethnicity, sex, and age<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, research suggests that genetics may account for 60&#8211;80% of bone mass variability, and protective genes like <italic toggle="yes">LRP5</italic> can help guide risk for astronauts. Naturally, any valuable omics-based countermeasures developed for bone health in space could spur innovations that benefit populations on Earth who suffer from bone loss, including the elderly, postmenopausal people, people with osteoporosis, and cancer patients who endure incidental bone loss after radiation treatment (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).</p></sec><sec id="Sec5"><title>Studying omics for improved spaceflight safety</title><p id="Par15">Of note, there are some published alleles (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>) that occur naturally in human populations, and which have been linked to protective mechanisms with possible relevance to spaceflight healthcare, which could help guide the countermeasure examples described above. The protective effects of some of these alleles appear to mechanistically overlap with nutrition and exercise interventions, and have motivated new clinical trials (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Hence, basic scientific research into the protective mechanisms of these alleles could one day translate into improved therapeutic compound discovery and better-informed nutrition, exercise, and lifestyle recommendations for crew members to maintain their health during deep space exploration. After reviewing these published alleles and their promising implications, we then follow with examples of the numerous technical and ethical difficulties involved with basic scientific research into the protective mechanisms linked to these alleles.<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Literature review of evidence for protective alleles.</title><p>Literature review and its key findings for a subset of alleles that may be linked to health protective effects, many of which occur naturally in the human population. From left to right: the gene name; example protective phenotypes; whether a polymorphism has been linked to the protective phenotype; whether the protective phenotype typically relates to over, under, or variant function of the gene; the level of evidence of protection for the variant on Earth (green icons) or in space (blue icons); and examples of known harmful associations with this allele. We further include if the gene or its related pathway can be targeted with exercise or nutrition (purple icon), has been studied in clinical trials (green icon), or has been observed to alter function during spaceflight. Only the highest level of evidence we found is displayed, with in vivo being defined as stronger evidence than in vitro, and health benefits for human subjects being defined as higher evidence than health benefits for rodent subjects. Empty cells indicate instances in which we were unable to find moderate evidence based on current literature. Partly created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license. More details and literature references are provided in the Supplementary Data.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e761" position="float" orientation="portrait" xlink:href="41467_2024_49423_Fig3_HTML.jpg"/></fig></p></sec><sec id="Sec6"><title>Human cohorts: Individuals</title><p id="Par16">Researchers discovered several of the alleles (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>) with protective mechanisms by studying special human cohorts, especially individuals with rare phenotypes. For example, a German toddler appeared &#8220;extraordinarily muscular&#8221; and was eventually diagnosed with a mutation in the myostatin-producing <italic toggle="yes">MSTN</italic> (<italic toggle="yes">GDF8</italic>) gene<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. The loss-of-function mutation translated into an absence of mature myostatin for the patient, who experienced gross muscle hypertrophy, with quadricep muscles 7.2 standard deviations (SD) above average and subcutaneous fat thickness 2.88&#8201;SD below the expected mean<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. <italic toggle="yes">MSTN</italic> targets are also being utilized in phase 2 clinical trials of humanized monoclonal <italic toggle="yes">MSTN</italic> antibodies, which confer increased muscle mass and strength in older individuals with recent falls<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, and thus could represent applications for astronauts as well. Resistance training and creatine supplementation to decrease myostatin serum levels have also been deployed based on individual profiles<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, which represent a non-omics intervention option for spaceflight.</p></sec><sec id="Sec7"><title>Human cohorts: Families</title><p id="Par17">Several other alleles have come to light through studying families with protective attributes. For example, genes linked to stronger bones (<italic toggle="yes">LRP5</italic>) and higher oxygen transport (<italic toggle="yes">EPOR</italic>) have been found in several family-based studies, and these protective pathways may be promising for spaceflight healthcare (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Specifically, the <italic toggle="yes">LRP5</italic> G171V mutation was discovered when family members showed strikingly high BMD in clinical screenings while reporting difficulty staying afloat while swimming and no history of bone fractures<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. The gain-of-function variant induces BMD about five times greater than the mean of the general population.</p><p id="Par18">The <italic toggle="yes">EPOR</italic> W439X mutation was found through linkage analysis of almost 100 family members<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. The mutation elicits the beneficial symptoms of erythrocytosis (such as increased hemoglobin count, hematocrit count, and oxygen transport capacity) with only mild or minimal negative effects<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Interestingly, one proband, who had hemoglobin &gt;200&#8201;g/L since childhood, was an Olympic gold medalist in cross-country skiing<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Annotating the network underpinnings of this allele could unravel new methods to combat clinical conditions that space travelers routinely suffer when exposed to altered gas composition in spacecraft.</p></sec><sec id="Sec8"><title>Human cohorts: Isolated populations</title><p id="Par19">Isolated populations have also revealed alleles linked to alleviated clinical manifestations of diseases like atherosclerosis and cancer (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). For instance, in a patient from Limone sul Garda (an isolated village in Northern Italy), the <italic toggle="yes">APOA1</italic> R173C mutation was associated with low high-density lipoprotein (HDL) levels and elevated triglycerides, but unexpectedly no atherosclerotic disease<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. When the complete Limone sul Garda population was sampled (<italic toggle="yes">n</italic>&#8201;=&#8201;1000 total), 33 living carriers of the &#8220;ApoA-1 Milano&#8221; mutation were identified<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, all with low HDL, and yet low incidence of heart disease. Genealogical analysis using church records suggested they were all possible descendants of one man born in the village in 1780<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Patients with acute coronary syndromes intravenously administered R173C phospholipid complexes show significant regression of coronary atherosclerosis<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p><p id="Par20">Studying the protective effects linked to <italic toggle="yes">APOA1</italic> could reveal new methods to mitigate the risk of myocardial infarction and atherosclerosis, especially since astronauts endure above-average radiation exposure<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>. However, it is still unclear whether spaceflight, particularly long-duration missions outside LEO, may increase long-term atherosclerotic risk<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Statins may reduce radiation-induced atherosclerosis, but published results are thus not conclusive. The absence of suitable prophylaxes for atherosclerosis risk in both terrestrial humans exposed to radiation and astronauts exposed to space radiation motivates the thorough analysis of the <italic toggle="yes">APOA1</italic> R173C mechanism to potentially uncover safe and effective therapeutic compounds.</p><p id="Par21">Additional examples of alleles linked to protective effects found in families include those related to Laron syndrome and genetic markers in Longevity Blue Zone (LBZ) populations. Laron syndrome is a rare condition that has been disproportionately reported in remote and inbred villages in the Loja province of Ecuador<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Patients typically have mutations in the <italic toggle="yes">GHR</italic> gene that are linked to growth hormone deficiency and decreased stature but are also linked to extended health span by potentially mitigating cancer and diabetes<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Given that cancer is a primary cause of death and a major health risk in upcoming long-term spaceflight, understanding the physiological underpinnings of <italic toggle="yes">GHR</italic> mutations associated with Laron syndrome could lead to potential anti-cancer therapies.</p><p id="Par22">LBZs are areas where the local population consists of unusually high numbers of elderly individuals. These LBZ populations have been identified in Sardinia and the Greek island of Ikaria. When compared to reference populations in Italy and Greece, LBZ populations show lower frequencies in genetic risk markers in <italic toggle="yes">APOE4</italic>, <italic toggle="yes">APOE2</italic>, and the TT allele of <italic toggle="yes">FOXO3</italic>, which are associated with an increased risk for Alzheimer&#8217;s disease and decreased cognitive function<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p></sec><sec id="Sec9"><title>Human cohorts: Populations adapted to extreme environments</title><p id="Par23">Research on human adaptation to extreme environments has also revealed alleles with health implications applicable to spaceflight (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>), including deep-diving adaptations in indigenous Bajau people and high-altitude adaptation in indigenous people of the Tibetan Plateau. Both populations have adapted to lifestyles in which the gas composition of their surroundings is uniquely altered compared to most human populations, potentially informing new approaches to combat physiological maladies that many astronauts endure due to altered gas composition (e.g. hypercapnia) on the ISS.</p><p id="Par24">The Bajau people, sometimes referred to as &#8220;Sea Nomads&#8221;, have lived marine hunter-gatherer lifestyles in Southeast Asian seas for over 1000 years<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. They are renowned for their remarkable breath-holding abilities, diving up to 73 meters using only wooden goggles and spending up to five hours each day apnea diving (breath-hold diving). One recent study found that Bajau people have significantly larger spleens than Saluan people, geographical neighbors with minimal marine-related lifestyles<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. The likely cause is natural selection on allelic variants in the <italic toggle="yes">PDE10A</italic> gene, which are associated with larger spleen size, providing them with additional reserves of oxygenated red blood cells. The study also found evidence of strong selection for variants in the <italic toggle="yes">BDKRB2</italic> gene, thought to increase peripheral vasoconstriction to preferentially redirect blood flow to critical tissues like the brain, heart, and lungs. Other candidate genes that appeared to be selected in the Bajau population included <italic toggle="yes">FAM178B</italic>, which encodes a protein that helps prevent the buildup of carbon dioxide, and <italic toggle="yes">CACNA1A</italic>, which regulates response to hypoxic conditions<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>.</p><p id="Par25">Insights into the genotypic physiology of hypoxia have not only emerged from populations who adapted to the seas, but also from those who adapted to the mountains. For millennia, people have lived on the Tibetan Plateau, which is surrounded by the two highest summits on Earth (Mount Everest and K2). The plateau averages ~4,000 meters above sea level and has 60% of the oxygen concentration and 130% of the UV radiation compared to sea level<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Several alleles were recently found under natural selection, likely due to the high-altitude lifestyle of this population<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>, including variants in the <italic toggle="yes">EGLN1</italic> (<italic toggle="yes">HIF-PH2</italic>) gene, which prevents degradation of hypoxia-inducible factors (HIFs). This HIF response allows for increased expression of hypoxia-inducible genes and confers a low hematocrit phenotype, which is advantageous in high altitudes and showed expression changes in the NASA Twins Study<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. The Tibetan population has an enrichment of mutations in the <italic toggle="yes">EPAS1</italic> (<italic toggle="yes">HIF-2A</italic>) gene, which encodes subunits of HIFs that contribute to the development of blood vessels and render a low hemoglobin phenotype, while reducing any negative fitness consequences of excess red blood cell production<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Moreover, alleles in the <italic toggle="yes">MTHFR</italic> gene tend to create a low homocysteine and high folate phenotype in the Tibetan population, which can provide protection from hyperhomocysteinemia, endothelial cell injury, inflammation of blood vessels, and ischemic injury. The high folate phenotype also provides compensatory protection from UV radiation exposure, given that UV radiation degrades folate and folic acid in human blood.</p><p id="Par26">Elucidating how the Bajau and Tibetan populations adapted to hypoxia may have clinical implications for people with conditions such as anemia, cytopenia, and hypoxia from intensive care treatment, tumorigenesis, and life in space. Also, carbon dioxide levels are typically higher on the ISS than on Earth and are associated with decreased cognitive scores and increased headaches in astronauts<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. Furthermore, gas composition in future Martian settlements could deviate at even greater ranges, given the atmospheric differences and unknown habitat designs.</p><p id="Par27">Humans have also experienced allelic adaptations to dietary habits, including lactase persistence from pastoralism in African populations<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> and modulation of fatty acid metabolism from fatty acid-rich diets in Greenland populations<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Although these specific diets may not have direct implications for space nutrition, spaceflight food is restricted, and the diets of space travelers significantly differ from nominal terrestrial diets. Investigation of the interaction of dietary habits and omics may one day lead to healthier solutions for the limited spaceflight menu and possibly survey how future Martian societies biologically adapt over multiple generations to their unique nutritional lifestyles.</p></sec><sec id="Sec10"><title>Studying omics for improved spaceflight nutrition</title><p id="Par28">Nutritional counseling based on omics has also benefited individuals with both rare (phenylketonuria) and common (lactose intolerance) genetic variants that entail customized dietary approaches<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Other evidence of genetic variants modifying responses to numerous nutrients and food bioactives has also emerged, including vitamins (A, B12, C, and D), fats (polyunsaturated and monounsaturated fatty acids), caffeine, calcium, choline, folate, and iron<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. Stratified outcomes were found for immunity, inflammation, the health of various organs (bone, heart, muscle, and liver), endurance, strength training recovery, and visuomotor skills, all of which can be pivotal for athletes, the young, or the elderly.</p><p id="Par29">Given the above evidence, omics metrics can also inform nutrition during space exploration. One unique example where this application has already proven meaningful relates to a distinctive ailment called spaceflight-associated neuro-ocular syndrome (SANS), which has no known terrestrial analogues. The disease appears to present in a subset of astronauts after short- and long-duration spaceflight, more so in men than women, and includes choroidal folds, optic disk edema (swelling), and focal areas of the ischemic retina (cotton wool spots). Research has suggested that SANS may be associated with lower levels of various types of vitamin B, combined with common variations in one-carbon metabolism genes<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. This intriguing finding illustrates the potential utility of omics to inform optimal nutrition during spaceflight.</p><p id="Par30">Dietary interventions specifically related to alleles listed in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref> could counteract space-induced inflammation. For example, several plant polyphenols can directly or indirectly activate <italic toggle="yes">SIRT1</italic>, which can reduce immune dysfunction, oxidative stress, autoimmunity, and inflammation<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. In addition to immunological issues in space, the human body stores more iron during spaceflight (e.g. NASA Twins Study), which has been linked to increased oxidative stress and decreased regional BMD, further underscoring the potential of plant-based, antioxidant interventions for spaceflight nutrition. Also, improved insulin resistance from <italic toggle="yes">SIRT1</italic> may share common biochemical pathways with numerous foods rich in polyphenols, including resveratrol (peanuts, grapes, and berries); piceatannol (Japanese knotweed); and fisetin (lotus root, persimmons, and apples)<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. Space crews often experience increased insulin resistance<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> and thus may benefit from consuming some nutritional derivatives, particularly those who are prone to possess low levels of <italic toggle="yes">SIRT1</italic>. Studying numerous other space-related allele variants displayed in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref> may similarly inform aerospace nutrition: The polyphenol curcumin increases <italic toggle="yes">LRP5</italic> messenger RNA (mRNA) expression and may instill similar bone-protective mechanisms of <italic toggle="yes">LRP5</italic> variants<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> as described above, the pigment &#946;-Carotene is linked to the anti-aging benefits similar to <italic toggle="yes">TERT</italic> overproduction variants and may mitigate telomere attrition<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>, flavones have inhibitory effects on <italic toggle="yes">MAFBX</italic> (<italic toggle="yes">FBXO32</italic>, <italic toggle="yes">ATROGIN-1</italic>) expression and may prevent myotube diameter reduction during muscle atrophy<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, and the plant alkaloid Berberine may inhibit <italic toggle="yes">PCSK9</italic> and reduce unhealthy cholesterol levels<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p><p id="Par31">Moreover, as astrobotany techniques progress, a wider selection of food crops could become successfully cultivable in space, and their nutritional and therapeutic properties could translate into valid countermeasures that avoid the negative side effects of pharmaceuticals and other space health approaches. Plant cells can deliver biomolecules that could benefit health in spaceflight: indeed, plants bioencapsulated with proinsulin have been shown to regulate blood sugar levels<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Metabolomics can help disentangle which space-farmed products may confer the most effective remedies for human illnesses during space exposure and which plants hold the greatest nutritional benefit per weight<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Plants in spaceflight can provide not only a wider assortment of nutrients, but also better air regeneration, water recycling, and mental health for astronauts, which could reduce flight risks. Also, discoveries in low-input and low-waste vegetation technology in space could be spun off to enhance sustainable agriculture back on Earth.</p></sec><sec id="Sec11"><title>Pharmacogenomics and optimized drug prescribing in space</title><p id="Par32">Spaceflight pharmacogenomics (SPGx) is the study of gene variants that influence the regulation of drug metabolism in space operations<sup><xref ref-type="bibr" rid="CR76">76</xref>,<xref ref-type="bibr" rid="CR77">77</xref></sup>. The drug-gene response can influence safety and efficacy, which can have a notable influence on health and performance. To date, there are roughly 570 drug-gene combinations used in terrestrial medicine for which pharmacogenomics-guided prescribing recommendations have been established by the FDA.</p><p id="Par33">One example of PGx relevant to spaceflight regards the phenomenon of statin-induced myopathy. Muscle loss in space remains a persistent challenge, so agents that facilitate myopathy in space are contraindicated. This can be contextualized by reviewing an investigation of a large military veteran cohort. Out of 7,769,356 veterans who took part in the study, nearly 55% took at least one drug with strong evidence of altered metabolism associated with a specific gene mutation over the six-year study period. Of particular concern, of the 533,928 participants who received new prescriptions of simvastatin, 25.6% were projected to have a SNP variant in <italic toggle="yes">SLC01B1</italic> (solute carrier organic anion transporter family member 1B1). The SLCO1B1*5 variant represents a loss&#8208;of&#8208;function allele known to attenuate the hepatic uptake of atorvastatin<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. This allele results in an increase in the amount of the parent drug in systemic circulation, which may put individuals at risk for myopathy, no matter the dose.</p><p id="Par34">The principle of PGx in space can be further illustrated by the case of codeine, which acts as a pain reliever via conversion to morphine by CYP450 2D6. Astronauts with the CYP450 2D6 slow metabolizer phenotype would be expected to convert only 10% of codeine to morphine. Therefore, codeine would be ineffective and should be removed from the mission drug list. Conversely, a 2D6 ultrarapid metabolizer will convert between 40 and 50% of codeine to morphine, which may result in morphine overdose and risk mission safety. In this case, codeine should be removed from the astronaut mission drug list because it is not safe<sup><xref ref-type="bibr" rid="CR79">79</xref>,<xref ref-type="bibr" rid="CR80">80</xref></sup>. Similar patterns have been seen for tramadol, where it may be ineffective for pain relief in slow metabolizers of CYP450 2D6. In 2D6 ultra-rapid metabolizers, the Dutch Pharmacogenetics Working Group recommends reducing tramadol dosage by 30% because of its tendency to produce symptoms such as nausea, vomiting, constipation, respiratory depression, confusion, and urinary retention<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>.</p><p id="Par35">Each of the above symptoms would be unideal or unacceptable on a space mission. Fortunately, many drug-associated adverse events are predictable and repeatable, because of known drug-gene dynamics. Spaceflight PGx can be used to tailor mission drug lists in such a way that drug efficacy can be optimized, drug side effects can be reduced, and astronaut safety and performance enhanced.</p></sec><sec id="Sec12"><title>Technical challenges of studying human space omics</title><p id="Par36">There are many challenges when studying genotype-phenotype interactions, both on Earth and in spaceflight. Engaging with national efforts (e.g. UK Biobank and the AllofUS program), as well as international groups like the International Standards for Space Omics Processing (ISSOP), can help develop standardization for space omics data and clinical applications<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. These efforts can help optimize the extraction of actionable scientific findings from spaceflight omics data and increase the probability of safe and effective countermeasures in aerospace healthcare.</p><p id="Par37">Alongside this promising side, we also follow with examples of the numerous technical and ethical difficulties involved with basic scientific research into the protective mechanisms linked to these alleles. For instance, the protective mechanisms associated with these alleles may present differently between in vitro and in vivo studies, study designs, and location (in space versus on Earth). These challenges are further convoluted by pleiotropy, whereby secondary effects may accompany or even outweigh protective effects. In addition, the small sample sizes in the human space omics discipline may also increase the risk of over-associating spaceflight omics changes with clinical meanings. Given these complexities, careful collection of standardized data and metadata; multi-omics profiling of consenting crew members before, during, and after spaceflight; and methodical production of cell space atlases could all be employed to better inform how to design safe and effective therapeutic compounds, meal plans, exercise equipment, and lifestyle recommendations that enhance protective effects and diminish harmful effects in space<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>.</p></sec><sec id="Sec13"><title>Statistical power, accuracy, and orthologs</title><p id="Par38">Some difficulties with mapping protective alleles (e.g. in genome-wide association studies, GWAS) include the lack of replicability, non-coding annotations, and population stratification, which also are relevant for any polygenic risk score (PRS). The generalizability of a PRS can be poor if the population of interest does not align with the ancestry of the original GWAS study, a fact that can perpetuate health disparities<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. Another difficulty relates to how evidence for genetic variations translates across populations, based on the impact of rare versus common variants and low effect sizes versus large effect sizes<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. For example, the <italic toggle="yes">MTHFR</italic> gene is known to be highly polymorphic, and studies linking the A222V allele to diseases have found conflicting results based on ancestry<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>. Potential solutions may require increasing sample sizes of study populations and accounting for factors like geographical location, genome reference, ancestry, sex, and age<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>.</p><p id="Par39">In addition, as shown in Supplementary Data&#160;<xref rid="MOESM3" ref-type="media">2</xref>, research into potentially protective alleles can sometimes have inconsistent findings between studies, and this may be partially due to experimental differences that must be clearly documented in metadata. The timeline of exposure is one of many metadata factors that can drastically change measured outcomes. Standardization of these metadata will be crucial to derive meaningful information from space omics studies<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>.</p></sec><sec id="Sec14"><title>Pleiotropic complications</title><p id="Par40">Eliciting protective genotype-phenotype relationships is also challenging because several gene variants linked to protective phenotypes can concurrently also be linked to negative, potentially fatal, phenotypes. For example, while overproduction of <italic toggle="yes">TERT</italic> is linked to decreased aging, it is also linked to cancer risk<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>; while variants of <italic toggle="yes">PCSK9</italic> are linked to decreased LDL and heart disease<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>, they are also linked to diabetes<sup><xref ref-type="bibr" rid="CR90">90</xref></sup> and low cognition<sup><xref ref-type="bibr" rid="CR91">91</xref></sup>; while <italic toggle="yes">CCR5</italic> variants are linked to decreased risks of cancer<sup><xref ref-type="bibr" rid="CR92">92</xref></sup>, HIV<sup><xref ref-type="bibr" rid="CR93">93</xref></sup> and diseases of the heart<sup><xref ref-type="bibr" rid="CR94">94</xref></sup>, liver<sup><xref ref-type="bibr" rid="CR95">95</xref></sup>, and brain<sup><xref ref-type="bibr" rid="CR96">96</xref></sup>, they also correspond to increased risks of various viruses like West Nile virus<sup><xref ref-type="bibr" rid="CR97">97</xref></sup>; and while <italic toggle="yes">CTNNB1</italic> overproduction is linked to radiation resistance<sup><xref ref-type="bibr" rid="CR98">98</xref></sup>, it is also linked to increased cancer risk<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>. To complicate the matter, downstream effects of gene variants can interact with each other; this is the case with <italic toggle="yes">SOST</italic> and <italic toggle="yes">LRP5</italic>, both related to bone health<sup><xref ref-type="bibr" rid="CR100">100</xref></sup>. Any nutrition and lifestyle recommendations, and any compounds developed, from basic studies of these alleles would need to meticulously ensure that concomitant negative effects are circumvented.</p><p id="Par41">Increasing the granularity of measures will allow for a better understanding of the cellular microenvironments and individual cellular subtypes, which could disentangle pleiotropic complications. Indeed, several papers referenced in Supplementary Data&#160;<xref rid="MOESM3" ref-type="media">2</xref> emphasize the need for cell-type-specific studies to further resolve the physiology of the alleles<sup><xref ref-type="bibr" rid="CR101">101</xref></sup>. Single cell sequencing technologies can generate high dimensional maps that resolve heterogeneous immunological cell types, allowing for better delineation of immune responses to various exposures and better interpretation of the immunosuppressive effects of spaceflight<sup><xref ref-type="bibr" rid="CR102">102</xref></sup>.</p><p id="Par42">One specific example is an overexpression of <italic toggle="yes">SIRT1</italic>, which could deliver protective phenotypes. However, <italic toggle="yes">SIRT1</italic> may increase the lifespan of rodent subjects when only overexpressed in particular regions, but not when overexpressed in the whole body<sup><xref ref-type="bibr" rid="CR103">103</xref>,<xref ref-type="bibr" rid="CR104">104</xref></sup>. Moreover, a global increase in the expression of <italic toggle="yes">SIRT1</italic> throughout all cells in the body may even confer negative effects, particularly within subset populations of T-helper cells, where it has been demonstrated to compromise differentiation. Hence, understanding optimal expression changes at the cell-type and lineage-specific level will be necessary to account for pleiotropic effects<sup><xref ref-type="bibr" rid="CR105">105</xref></sup>.</p></sec><sec id="Sec15"><title>Space-relevant harmful alleles</title><p id="Par43">We note that there are naturally occurring human alleles we did not highlight in this paper that are, in contrast, primarily known to be linked to space-related harmful effects. For example, mutations in the <italic toggle="yes">ATM</italic> gene may cause the disorder ataxia telangiectasia, and mutations in the <italic toggle="yes">NBS1</italic> gene may cause Nijmegen breakage syndrome; in both cases, affected individuals can show chromosomal instability, radiation sensitivity, and cancer susceptibility<sup><xref ref-type="bibr" rid="CR106">106</xref>&#8211;<xref ref-type="bibr" rid="CR108">108</xref></sup>. Additional genes related to DNA repair, radiation sensitivity, and cancer predisposition include <italic toggle="yes">RAD50</italic>, <italic toggle="yes">BRCA1, BRCA2, P53</italic>, among many others<sup><xref ref-type="bibr" rid="CR109">109</xref>&#8211;<xref ref-type="bibr" rid="CR111">111</xref></sup>. Investigating these alleles may guide risk reduction during space exploration, as well as for any type of experience on Earth in which individuals are exposed to higher-than-average amounts of radiation.</p><p id="Par44">Another example is the I148M variant of the <italic toggle="yes">PNPLA3</italic> gene, associated with an increased risk of chronic liver disease<sup><xref ref-type="bibr" rid="CR112">112</xref></sup>. Interestingly, harmful effects of the <italic toggle="yes">PNPLA3</italic> I148M mutation can be mitigated by one of the protective variants we listed in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref> (the rs72613567 variant of the <italic toggle="yes">HSD17B13</italic> gene) in an allele and dose-dependent manner<sup><xref ref-type="bibr" rid="CR113">113</xref></sup>. Counteracting risk for liver disease could be important, since space stressors may activate lipotoxic pathways that further elevate liver disease risk, potentially leading to lipid dysregulation and reduced immune activity in susceptible spaceflight participants<sup><xref ref-type="bibr" rid="CR114">114</xref>,<xref ref-type="bibr" rid="CR115">115</xref></sup>.</p><p id="Par45">In exploring genetic markers that confer potential risk in space, it is useful to further explore the APOE4/4 (APOE4) genotype in the context of novel exposures and cognitive changes. For example, there is a well-established phenomenon of chemotherapy-related cognitive impairment (CRCI), which appears to be increased in APOE4 carriers<sup><xref ref-type="bibr" rid="CR116">116</xref></sup>. In survivors of breast cancer who had undergone chemotherapy, APOE4 carriers had worse visual memory and spatial ability when examined five years after diagnosis. In breast cancer survivors, those APOE4 carriers undergoing chemotherapy had significantly lower scores on measures of working memory and processing speed when examined at 1-, 6-, and 18-months post-treatment<sup><xref ref-type="bibr" rid="CR117">117</xref></sup>. In another study, APOE4 breast cancer survivors treated with cytostatics had lower scores on executive function, attention, and processing speed at one- and two-years post-treatment<sup><xref ref-type="bibr" rid="CR118">118</xref></sup>. Moreover, radiation-induced cognitive decline shows similar deficits in cognition. Cramer et al. showed that, among patients undergoing therapeutic brain irradiation, roughly 30% experience cognitive decline by 4 months. In those living over 6 months, the rate increases to 50% or greater<sup><xref ref-type="bibr" rid="CR119">119</xref></sup>. Makale et al. have reported that 50-90% of those undergoing partial or whole brain cranial radiation experience disabling cognitive impairment (thought APOE status was not assessed by Cramer or Makale)<sup><xref ref-type="bibr" rid="CR120">120</xref></sup>.</p><p id="Par46">There is a paucity of human data related to APOE4 and spaceflight-associated cognitive risks. If the APOE4 genotype confers additional risk to cognitive decline in the presence of an exogenous stressor like space radiation, this would warrant careful attention to the APOE4 genotype in the future design of experiments concerning human spaceflight. It will also be important to determine whether the APOE2/2 genotype may be protective against cognitive decline in space in a manner similar to the protective effects of APOE2 on cognition on Earth.</p><p id="Par47">To illustrate one final example, the R506Q mutation of the <italic toggle="yes">F5</italic> gene (Factor V Leiden) is one of the most common inherited susceptibilities to thrombophilia (blood clotting). The likelihood of blood clotting, which can be life-threatening, increases up to 7-fold in heterozygous carriers and up to 80-fold in homozygous individuals<sup><xref ref-type="bibr" rid="CR121">121</xref></sup>. Immobility (such as during flight travel), increased estrogen levels (such as during pregnancy, hormone replacement therapy, and oral contraceptive use), and injuries (such as fractured bones) can further increase the risk for affected individuals<sup><xref ref-type="bibr" rid="CR122">122</xref></sup>. Astronauts are frequently exposed to these associated risks, given the immobile nature of orbital flights, the personal decision by some participants to suppress menstruation with oral contraceptives during space missions, and the projected heightened risk of bone fractures in long-duration spaceflight<sup><xref ref-type="bibr" rid="CR123">123</xref></sup>. Individuals could select specific countermeasures for blood clotting (such as compression stockings and anticoagulant substances) based on their personal risk profiles<sup><xref ref-type="bibr" rid="CR124">124</xref></sup>.</p></sec><sec id="Sec16"><title>Ethical challenges of studying human space omics</title><p id="Par48">As discussed in this paper, the landscape of human spaceflight has entered a transformative period of democratization, with increased commercial flight opportunities and collaborative agreements between government and private entities<sup><xref ref-type="bibr" rid="CR125">125</xref></sup>. This increased diversity in mission formats, flight objectives, and stakeholders is creating a ripple effect on ethics and regulation. Indeed, many policy discussions in the context of human research and healthcare in space that were once internal to government institutions now fall under the remit of the public forum, as discussed elsewhere<sup><xref ref-type="bibr" rid="CR126">126</xref></sup>. Widened discussion of policy has been further expedited by a push for open science, reflected through international data sharing and collaboration initiatives, including the NASA Open Science Data Repository<sup><xref ref-type="bibr" rid="CR127">127</xref></sup> and the EXPAND (Enhancing eXploration Platforms and Analog Definition) program of the Translational Research Institute for Space Health (TRISH)<sup><xref ref-type="bibr" rid="CR128">128</xref></sup>.</p><p id="Par49">Space agencies and commercial entities seek to identify biomarkers for spaceflight health effects to refine risk prediction, optimize mission planning, and elevate the standard of care for humans in space via improved countermeasures. In this paper, we have reviewed a number of published alleles naturally occurring in humans on Earth, and we have suggested their potential influence on the body&#8217;s response to the spaceflight environment. The use of allelic information for optimizing precision healthcare is commonplace on Earth, such as to avoid adverse reactions during drug prescriptions<sup><xref ref-type="bibr" rid="CR129">129</xref></sup>, identify high-risk individuals to preemptively screen for disease onset, or refine diagnosis and inform therapeutic approach<sup><xref ref-type="bibr" rid="CR130">130</xref></sup>. Similarly, allelic information and other omics could be used to optimize healthcare in space, such as through integration into precision healthcare strategies for government and commercial crew, the advent of which has been discussed elsewhere<sup><xref ref-type="bibr" rid="CR131">131</xref></sup>. Of note, care should be taken that these alleles are not used for discriminatory practices, and updated legislation like the Genetic Information Non-Discrimination Act (GINA) may be needed to account for the new risk paradigm of spaceflight and long-term care or life insurance.</p><p id="Par50">In terrestrial healthcare, emergent omics approaches also include genetic and epigenetic modification therapies<sup><xref ref-type="bibr" rid="CR132">132</xref></sup>. If safely established on Earth, in the far future, one can imagine that similar modification therapies may eventually be investigated as candidate interventions for increased health and safety in crewed spaceflight, such as to protect against space stressors during long-duration missions to Mars, the outer solar system, and even beyond, as recently discussed<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR105">105</xref></sup>. While beyond the scope of this manuscript, we note that gene therapy is a particularly controversial subject matter, and its associated ethical challenges have been discussed elsewhere in the context of human spaceflight<sup><xref ref-type="bibr" rid="CR133">133</xref>,<xref ref-type="bibr" rid="CR134">134</xref></sup>.</p></sec></sec><sec id="Sec17" sec-type="discussion"><title>Discussion</title><p id="Par51">In the foreseeable future, collecting, storing, and sharing omics data from consenting humans venturing into space for use in research and terrestrially established occupational healthcare strategies also requires careful policy to address a multitude of ethical challenges. Indeed, ethical challenges include developing data accessibility and sharing strategies without violation of privacy of individuals and family members, achieving meaningful informed consent throughout the entire data lifecycle, avoiding uses of data that support actions of a discriminatory or inequitable nature, ensuring thorough and expert ethical oversight of projects, and appropriately handling any incidental findings from the data<sup><xref ref-type="bibr" rid="CR134">134</xref></sup>, as well as issues regarding the challenge of protecting astronauts<sup><xref ref-type="bibr" rid="CR135">135</xref>,<xref ref-type="bibr" rid="CR136">136</xref></sup>. Just as the landscape of human spaceflight is diversifying in a positive and more inclusive manner, so too are the opportunities for improving precision healthcare in flight and on longer missions<sup><xref ref-type="bibr" rid="CR137">137</xref></sup>. For example, with genetic risk data in hand, individuals could exercise increased autonomy in making informed decisions about participating in spaceflight activities.</p><p id="Par52">In this paper, we reviewed an example set of published alleles purportedly linked to protective effects, the biochemical pathways of which could inform therapeutic compound discovery and nutrition, exercise, and lifestyle recommendations to protect health during spaceflight missions and potentially during postflight recovery and stationing on planetary surfaces, including the Moon and Mars<sup><xref ref-type="bibr" rid="CR138">138</xref></sup>. This guide can also help individuals on Earth in high-stress and environmentally challenging scenarios, such as first responders, cave explorers, radiation workers, deep-sea investigators, or commercial astronauts like the Inspiration4, Axoim Space, and Polaris Dawn missions<sup><xref ref-type="bibr" rid="CR91">91</xref>,<xref ref-type="bibr" rid="CR139">139</xref>&#8211;<xref ref-type="bibr" rid="CR147">147</xref></sup>. Alongside any untapped potential to enhance both terrestrial and aerospace precision healthcare, investigation of such alleles poses significant technical and ethical challenges. If humanity safely and effectively surmounts these hurdles, the revamped aerospace health recommendations that ensue could be incorporated with other types of countermeasures (such as artificial gravity, faster spacecraft, radiation shielding, and biotechnology for food and material production) in order to best preserve the well-being of life during future deep space missions and interplanetary exploration.</p></sec><sec sec-type="supplementary-material"><sec id="Sec18"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2024_49423_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2024_49423_MOESM2_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2024_49423_MOESM3_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2024_49423_MOESM4_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Data 1 References</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2024_49423_MOESM5_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Data 2 References</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-024-49423-6.</p></sec><ack><title>Acknowledgements</title><p>The authors thank Sergey Ponomarev (IBMP Russian Academy of Sciences), Ra&#250;l Herranz (Centro de Investigaciones Biol&#243;gicas &#8220;Margarita Salas&#8221; (CSIC)), Liz Warren (Blue Origin), Ryan T. Scott (KBR; NASA Ames Research Center), Deanne Taylor (University of Pennsylvania), and Richard Barker (University of Wisconsin-Madison). Selected elements from Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> were created with BioRender.com. LAR and MM are supported by the Japan Society for the Promotion of Science (JSPS) funding JP15H05940 and JP20H03234. LAR is supported by the JSPS postdoctoral fellowship P20382. European (HC, NJS, and SG) contribution is supported by the ESA Topical Team &#8220;Space Omics: Towards an integrated ESA/NASA-omics database for spaceflight and ground facilities experiments&#8221; grant 4000131202/20/NL/PG/pt. SG is supported by Formas grant 2017-01066_3. HC is supported by the Horizon Centre for Doctoral Training at the University of Nottingham (UKRI Grant No. EP/S023305/1). NJS is supported by NASA (NSSC22K0250, NSSC22K0278). CEM thanks the WorldQuant Foundation, NASA (NNX14AH50G, NNX17AB26G, 80NSSC23K0832, 80NSSC22K0254, NNH18ZTT001N-FG2), the National Institutes of Health (R01MH117406, P01CA214274, R01AI151059, R01CA249054, 7029-23), and the LLS (MCL7001-18, LLS 9238-16).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: L.A.R., M.J.M., H.C., N.J.S., M.M., B.L., G.M.C., S.G., and C.E.M.. Methodology: L.A.R., M.J.M., B.L., S.G., and C.E.M. Software: M.J.M. Formal Analysis: L.A.R. and M.J.M. Investigation: L.A.R., M.J.M., S.G., E.O., and C.E.M.. Resources: C.E.M. Data Curation: L.A.R., M.J.M., and B.T. Writing-Original Draft: L.A.R., B.L., and C.E.M. Writing-Review and Editing: L.A.R., H.C., N.J.S., J.K., B.T., M.M., B.L., D.B., E.O., A.M.P., G.M.C., S.G., M.A.S., and C.E.M. Visualization: L.A.R. and M.J.M. Supervision: N.J.S., M.M., S.G., and C.E.M. Project Administration: S.G. and C.E.M. Funding Acquisition: N.J.S., M.M., S.G., and C.E.M.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par53"><italic toggle="yes">Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work.</p></sec></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par54">Christopher E. Mason is the Co-Founder of Onegevity Health. Daniela Bezdan is the Co-founder of Poppy Health, Inc. and CSO of Yuri GmbH. Stefania Giacomello is scientific advisor to 10x Genomics, which holds IP rights to the ST technology and holds stocks. George M. Church is an advisor to 10x Genomics, Colossal, Copernicus, etc, details here: v.ht/PHNc. The remaining authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><collab>Fundamental Biological Features of Spaceflight.</collab></person-group><article-title>Advancing the field to enable deep-space exploration</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1162</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.050</pub-id><pub-id pub-id-type="pmid">33242416</pub-id><pub-id pub-id-type="pmcid">PMC8441988</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Fundamental Biological Features of Spaceflight. Advancing the field to enable deep-space exploration. <italic toggle="yes">Cell</italic><bold>183</bold>, 1162&#8211;1184 (2020).<pub-id pub-id-type="pmid">33242416</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.050</pub-id><pub-id pub-id-type="pmcid">PMC8441988</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>MA</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>TJ</given-names></name></person-group><article-title>Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance</article-title><source>Metabolomics</source><year>2013</year><volume>9</volume><fpage>1134</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1007/s11306-013-0556-3</pub-id><pub-id pub-id-type="pmid">24273472</pub-id><pub-id pub-id-type="pmcid">PMC3825629</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Schmidt, M. A. &amp; Goodwin, T. J. Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance. <italic toggle="yes">Metabolomics</italic><bold>9</bold>, 1134&#8211;1156 (2013). pp.<pub-id pub-id-type="pmid">24273472</pub-id><pub-id pub-id-type="doi">10.1007/s11306-013-0556-3</pub-id><pub-id pub-id-type="pmcid">PMC3825629</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cope</surname><given-names>H</given-names></name><etal/></person-group><article-title>Routine omics collection is a golden opportunity for European human research in space and analog environments</article-title><source>Patterns</source><year>2022</year><volume>3</volume><fpage>100550</fpage><pub-id pub-id-type="doi">10.1016/j.patter.2022.100550</pub-id><pub-id pub-id-type="pmid">36277820</pub-id><pub-id pub-id-type="pmcid">PMC9583032</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cope, H. et al. Routine omics collection is a golden opportunity for European human research in space and analog environments. <italic toggle="yes">Patterns</italic><bold>3</bold>, 100550 (2022).<pub-id pub-id-type="pmid">36277820</pub-id><pub-id pub-id-type="doi">10.1016/j.patter.2022.100550</pub-id><pub-id pub-id-type="pmcid">PMC9583032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Ruyters, G., Stang, K. Space medicine 2025 &#8211; A vision. REACH. 55&#8211;62 (2016).</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennett</surname><given-names>JM</given-names></name><etal/></person-group><article-title>The evolution of critical thermal limits of life on Earth</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1198</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21263-8</pub-id><pub-id pub-id-type="pmid">33608528</pub-id><pub-id pub-id-type="pmcid">PMC7895938</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Bennett, J. M. et al. The evolution of critical thermal limits of life on Earth. <italic toggle="yes">Nat. Commun.</italic><bold>12</bold>, 1198 (2021).<pub-id pub-id-type="pmid">33608528</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-21263-8</pub-id><pub-id pub-id-type="pmcid">PMC7895938</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Garrett-Bakelman, F. E., et al. The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight. <italic toggle="yes">Science</italic>. 364 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aau8650</pub-id><pub-id pub-id-type="pmcid">PMC7580864</pub-id><pub-id pub-id-type="pmid">30975860</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Biomanufacturing of 3D tissue constructs in microgravity and their applications in human pathophysiological studies</article-title><source>Adv. Health. Mater.</source><year>2023</year><volume>12</volume><fpage>e2300157</fpage><pub-id pub-id-type="doi">10.1002/adhm.202300157</pub-id><pub-id pub-id-type="pmid">37483106</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Ren, Z. et al. Biomanufacturing of 3D tissue constructs in microgravity and their applications in human pathophysiological studies. <italic toggle="yes">Adv. Health. Mater.</italic><bold>12</bold>, e2300157 (2023).<pub-id pub-id-type="doi">10.1002/adhm.202300157</pub-id><pub-id pub-id-type="pmid">37483106</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chancellor</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Limitations in predicting the space radiation health risk for exploration astronauts</article-title><source>NPJ Microgravity</source><year>2018</year><volume>4</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s41526-018-0043-2</pub-id><pub-id pub-id-type="pmid">29644336</pub-id><pub-id pub-id-type="pmcid">PMC5882936</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Chancellor, J. C. et al. Limitations in predicting the space radiation health risk for exploration astronauts. <italic toggle="yes">NPJ Microgravity</italic><bold>4</bold>, 8 (2018).<pub-id pub-id-type="pmid">29644336</pub-id><pub-id pub-id-type="doi">10.1038/s41526-018-0043-2</pub-id><pub-id pub-id-type="pmcid">PMC5882936</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obrador</surname><given-names>E</given-names></name><etal/></person-group><article-title>Radioprotection and Radiomitigation: From the bench to clinical practice</article-title><source>Biomedicines</source><year>2020</year><volume>8</volume><fpage>461</fpage><pub-id pub-id-type="doi">10.3390/biomedicines8110461</pub-id><pub-id pub-id-type="pmid">33142986</pub-id><pub-id pub-id-type="pmcid">PMC7692399</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Obrador, E. et al. Radioprotection and Radiomitigation: From the bench to clinical practice. <italic toggle="yes">Biomedicines</italic><bold>8</bold>, 461 (2020).<pub-id pub-id-type="pmid">33142986</pub-id><pub-id pub-id-type="doi">10.3390/biomedicines8110461</pub-id><pub-id pub-id-type="pmcid">PMC7692399</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopewell</surname><given-names>JW</given-names></name></person-group><article-title>Models of CNS radiation damage during space flight</article-title><source>Adv. Space Res</source><year>1994</year><volume>14</volume><fpage>433</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/0273-1177(94)90497-9</pub-id><pub-id pub-id-type="pmid">11539980</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Hopewell, J. W. Models of CNS radiation damage during space flight. <italic toggle="yes">Adv. Space Res</italic><bold>14</bold>, 433&#8211;442 (1994).<pub-id pub-id-type="pmid">11539980</pub-id><pub-id pub-id-type="doi">10.1016/0273-1177(94)90497-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Moreels, M., de Saint-Georges, L., Vanhavere, F., Baatout, S. Stress and radiation responsiveness. <italic toggle="yes">Stress Challenges Immun. Space</italic>. 239&#8211;260 (2012).</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cortese</surname><given-names>F</given-names></name><etal/></person-group><article-title>Vive la radior&#233;sistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>14692</fpage><lpage>14722</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.24461</pub-id><pub-id pub-id-type="pmid">29581875</pub-id><pub-id pub-id-type="pmcid">PMC5865701</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Cortese, F. et al. Vive la radior&#233;sistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization. <italic toggle="yes">Oncotarget</italic><bold>9</bold>, 14692&#8211;14722 (2018).<pub-id pub-id-type="pmid">29581875</pub-id><pub-id pub-id-type="doi">10.18632/oncotarget.24461</pub-id><pub-id pub-id-type="pmcid">PMC5865701</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Restier-Verlet</surname><given-names>J</given-names></name><etal/></person-group><article-title>Radiation on Earth or in space: What does it change?</article-title><source>Int J. Mol. Sci.</source><year>2021</year><volume>22</volume><fpage>3739</fpage><pub-id pub-id-type="doi">10.3390/ijms22073739</pub-id><pub-id pub-id-type="pmid">33916740</pub-id><pub-id pub-id-type="pmcid">PMC8038356</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Restier-Verlet, J. et al. Radiation on Earth or in space: What does it change? <italic toggle="yes">Int J. Mol. Sci.</italic><bold>22</bold>, 3739 (2021).<pub-id pub-id-type="pmid">33916740</pub-id><pub-id pub-id-type="doi">10.3390/ijms22073739</pub-id><pub-id pub-id-type="pmcid">PMC8038356</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Durante, M., Manti, L. Human response to high-background radiation environments on Earth and in space. <italic toggle="yes">Adv. Space Res.</italic> 999&#8211;1007 (2008).</mixed-citation></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cucinotta</surname><given-names>FA</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M-HY</given-names></name><name name-style="western"><surname>Willingham</surname><given-names>V</given-names></name><name name-style="western"><surname>George</surname><given-names>KA</given-names></name></person-group><article-title>Physical and biological organ dosimetry analysis for international space station astronauts</article-title><source>Radiat. Res</source><year>2008</year><volume>170</volume><fpage>127</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1667/RR1330.1</pub-id><pub-id pub-id-type="pmid">18582161</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Cucinotta, F. A., Kim, M.-H. Y., Willingham, V. &amp; George, K. A. Physical and biological organ dosimetry analysis for international space station astronauts. <italic toggle="yes">Radiat. Res</italic><bold>170</bold>, 127&#8211;138 (2008).<pub-id pub-id-type="pmid">18582161</pub-id><pub-id pub-id-type="doi">10.1667/RR1330.1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cucinotta</surname><given-names>FA</given-names></name><name name-style="western"><surname>Durante</surname><given-names>M</given-names></name></person-group><article-title>Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings</article-title><source>Lancet Oncol.</source><year>2006</year><volume>7</volume><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(06)70695-7</pub-id><pub-id pub-id-type="pmid">16648048</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Cucinotta, F. A. &amp; Durante, M. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. <italic toggle="yes">Lancet Oncol.</italic><bold>7</bold>, 431&#8211;435 (2006).<pub-id pub-id-type="pmid">16648048</pub-id><pub-id pub-id-type="doi">10.1016/S1470-2045(06)70695-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cucinotta</surname><given-names>FA</given-names></name><name name-style="western"><surname>Cacao</surname><given-names>E</given-names></name></person-group><article-title>Non-targeted effects models predict significantly higher mars mission cancer risk than targeted effects models</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1832</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-02087-3</pub-id><pub-id pub-id-type="pmid">28500351</pub-id><pub-id pub-id-type="pmcid">PMC5431989</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Cucinotta, F. A. &amp; Cacao, E. Non-targeted effects models predict significantly higher mars mission cancer risk than targeted effects models. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 1832 (2017).<pub-id pub-id-type="pmid">28500351</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-02087-3</pub-id><pub-id pub-id-type="pmcid">PMC5431989</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iosim</surname><given-names>S</given-names></name><name name-style="western"><surname>MacKay</surname><given-names>M</given-names></name><name name-style="western"><surname>Westover</surname><given-names>C</given-names></name><name name-style="western"><surname>Mason</surname><given-names>CE</given-names></name></person-group><article-title>Translating current biomedical therapies for long duration, deep space missions</article-title><source>Precis Clin. Med.</source><year>2019</year><volume>2</volume><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1093/pcmedi/pbz022</pub-id><pub-id pub-id-type="pmid">31886035</pub-id><pub-id pub-id-type="pmcid">PMC6927098</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Iosim, S., MacKay, M., Westover, C. &amp; Mason, C. E. Translating current biomedical therapies for long duration, deep space missions. <italic toggle="yes">Precis Clin. Med.</italic><bold>2</bold>, 259&#8211;269 (2019).<pub-id pub-id-type="pmid">31886035</pub-id><pub-id pub-id-type="doi">10.1093/pcmedi/pbz022</pub-id><pub-id pub-id-type="pmcid">PMC6927098</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durante</surname><given-names>M</given-names></name></person-group><article-title>Space radiation protection: Destination Mars</article-title><source>Life Sci. Space Res.</source><year>2014</year><volume>1</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.lssr.2014.01.002</pub-id><pub-id pub-id-type="pmid">26432587</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Durante, M. Space radiation protection: Destination Mars. <italic toggle="yes">Life Sci. Space Res.</italic><bold>1</bold>, 2&#8211;9 (2014).<pub-id pub-id-type="doi">10.1016/j.lssr.2014.01.002</pub-id><pub-id pub-id-type="pmid">26432587</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Clancy P., Brack A., Horneck, G. Looking for Life, Searching the Solar System. Cambridge University Press; 2005.</mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Zwart</surname><given-names>SR</given-names></name></person-group><article-title>Chapter 3 nutritional biochemistry of spaceflight</article-title><source>Adv. Clin. Chem.</source><year>2008</year><volume>46</volume><fpage>87</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/S0065-2423(08)00403-4</pub-id><pub-id pub-id-type="pmid">19004188</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Smith, S. M. &amp; Zwart, S. R. Chapter 3 nutritional biochemistry of spaceflight. <italic toggle="yes">Adv. Clin. Chem.</italic><bold>46</bold>, 87&#8211;130 (2008). pp.<pub-id pub-id-type="pmid">19004188</pub-id><pub-id pub-id-type="doi">10.1016/S0065-2423(08)00403-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durante</surname><given-names>M</given-names></name><name name-style="western"><surname>Cucinotta</surname><given-names>FA</given-names></name></person-group><article-title>Heavy ion carcinogenesis and human space exploration</article-title><source>Nat. Rev. Cancer</source><year>2008</year><volume>8</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/nrc2391</pub-id><pub-id pub-id-type="pmid">18451812</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Durante, M. &amp; Cucinotta, F. A. Heavy ion carcinogenesis and human space exploration. <italic toggle="yes">Nat. Rev. Cancer</italic><bold>8</bold>, 465&#8211;472 (2008).<pub-id pub-id-type="pmid">18451812</pub-id><pub-id pub-id-type="doi">10.1038/nrc2391</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Ponder B. A. J. Cancer genetics. <italic toggle="yes">Nature</italic>. 336&#8211;341 (2001).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/35077207</pub-id><pub-id pub-id-type="pmid">11357140</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foray</surname><given-names>N</given-names></name><name name-style="western"><surname>Bourguignon</surname><given-names>M</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>N</given-names></name></person-group><article-title>Individual response to ionizing radiation</article-title><source>Mutat. Res.</source><year>2016</year><volume>770</volume><fpage>369</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.mrrev.2016.09.001</pub-id><pub-id pub-id-type="pmid">27919342</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Foray, N., Bourguignon, M. &amp; Hamada, N. Individual response to ionizing radiation. <italic toggle="yes">Mutat. Res.</italic><bold>770</bold>, 369&#8211;386 (2016).<pub-id pub-id-type="doi">10.1016/j.mrrev.2016.09.001</pub-id><pub-id pub-id-type="pmid">27919342</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavez Lori&#232;</surname><given-names>E</given-names></name><etal/></person-group><article-title>The future of personalized medicine in space: from observations to countermeasures</article-title><source>Front Bioeng. Biotechnol.</source><year>2021</year><volume>9</volume><fpage>739747</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2021.739747</pub-id><pub-id pub-id-type="pmid">34966726</pub-id><pub-id pub-id-type="pmcid">PMC8710508</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Pavez Lori&#232;, E. et al. The future of personalized medicine in space: from observations to countermeasures. <italic toggle="yes">Front Bioeng. Biotechnol.</italic><bold>9</bold>, 739747 (2021).<pub-id pub-id-type="pmid">34966726</pub-id><pub-id pub-id-type="doi">10.3389/fbioe.2021.739747</pub-id><pub-id pub-id-type="pmcid">PMC8710508</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonsen</surname><given-names>EL</given-names></name><name name-style="western"><surname>Reed</surname><given-names>RD</given-names></name></person-group><article-title>Policy considerations for precision medicine in human spaceflight</article-title><source>Hous. J. Health L Pol&#8217;y</source><year>2019</year><volume>19</volume><fpage>1</fpage></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Antonsen, E. L. &amp; Reed, R. D. Policy considerations for precision medicine in human spaceflight. <italic toggle="yes">Hous. J. Health L Pol&#8217;y</italic><bold>19</bold>, 1 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>EM</given-names></name><name name-style="western"><surname>Day</surname><given-names>R</given-names></name><name name-style="western"><surname>Singh</surname><given-names>VK</given-names></name></person-group><article-title>New approaches to radiation protection</article-title><source>Front Oncol.</source><year>2014</year><volume>4</volume><fpage>381</fpage><pub-id pub-id-type="pmid">25653923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2014.00381</pub-id><pub-id pub-id-type="pmcid">PMC4299410</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Rosen, E. M., Day, R. &amp; Singh, V. K. New approaches to radiation protection. <italic toggle="yes">Front Oncol.</italic><bold>4</bold>, 381 (2014).<pub-id pub-id-type="pmid">25653923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2014.00381</pub-id><pub-id pub-id-type="pmcid">PMC4299410</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeBlanc</surname><given-names>AD</given-names></name><name name-style="western"><surname>Spector</surname><given-names>ER</given-names></name><name name-style="western"><surname>Evans</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Sibonga</surname><given-names>JD</given-names></name></person-group><article-title>Skeletal responses to space flight and the bed rest analog: a review</article-title><source>J. Musculoskelet. Neuronal. Interact.</source><year>2007</year><volume>7</volume><fpage>33</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17396004</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">LeBlanc, A. D., Spector, E. R., Evans, H. J. &amp; Sibonga, J. D. Skeletal responses to space flight and the bed rest analog: a review. <italic toggle="yes">J. Musculoskelet. Neuronal. Interact.</italic><bold>7</bold>, 33&#8211;47 (2007).<pub-id pub-id-type="pmid">17396004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Oganov, V. S., Bogomolov, V. V. The human skeletal system in weightlessness: A review of research data, hypotheses, and the possibility of predicting the state in long-term (Interplanetary) missions. <italic toggle="yes">Hum. Physiol.</italic> 768&#8211;776 (2011).</mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabel</surname><given-names>L</given-names></name><etal/></person-group><article-title>Incomplete recovery of bone strength and trabecular microarchitecture at the distal tibia 1 year after return from long duration spaceflight</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>9446</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-13461-1</pub-id><pub-id pub-id-type="pmid">35773442</pub-id><pub-id pub-id-type="pmcid">PMC9247070</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Gabel, L. et al. Incomplete recovery of bone strength and trabecular microarchitecture at the distal tibia 1 year after return from long duration spaceflight. <italic toggle="yes">Sci. Rep.</italic><bold>12</bold>, 9446 (2022).<pub-id pub-id-type="pmid">35773442</pub-id><pub-id pub-id-type="doi">10.1038/s41598-022-13461-1</pub-id><pub-id pub-id-type="pmcid">PMC9247070</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Axpe</surname><given-names>E</given-names></name><etal/></person-group><article-title>A human mission to Mars: Predicting the bone mineral density loss of astronauts</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><fpage>e0226434</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0226434</pub-id><pub-id pub-id-type="pmid">31967993</pub-id><pub-id pub-id-type="pmcid">PMC6975633</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Axpe, E. et al. A human mission to Mars: Predicting the bone mineral density loss of astronauts. <italic toggle="yes">PLoS One</italic><bold>15</bold>, e0226434 (2020).<pub-id pub-id-type="pmid">31967993</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0226434</pub-id><pub-id pub-id-type="pmcid">PMC6975633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo</surname><given-names>H</given-names></name><etal/></person-group><article-title>Oxidative stress and gamma radiation-induced cancellous bone loss with musculoskeletal disuse</article-title><source>J. Appl. Physiol.</source><year>2010</year><volume>108</volume><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00294.2009</pub-id><pub-id pub-id-type="pmid">19875718</pub-id><pub-id pub-id-type="pmcid">PMC2885070</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kondo, H. et al. Oxidative stress and gamma radiation-induced cancellous bone loss with musculoskeletal disuse. <italic toggle="yes">J. Appl. Physiol.</italic><bold>108</bold>, 152&#8211;161 (2010).<pub-id pub-id-type="pmid">19875718</pub-id><pub-id pub-id-type="doi">10.1152/japplphysiol.00294.2009</pub-id><pub-id pub-id-type="pmcid">PMC2885070</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baxter</surname><given-names>NN</given-names></name><name name-style="western"><surname>Habermann</surname><given-names>EB</given-names></name><name name-style="western"><surname>Tepper</surname><given-names>JE</given-names></name><name name-style="western"><surname>Durham</surname><given-names>SB</given-names></name><name name-style="western"><surname>Virnig</surname><given-names>BA</given-names></name></person-group><article-title>Risk of pelvic fractures in older women following pelvic irradiation</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>2587</fpage><lpage>2593</lpage><pub-id pub-id-type="doi">10.1001/jama.294.20.2587</pub-id><pub-id pub-id-type="pmid">16304072</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Baxter, N. N., Habermann, E. B., Tepper, J. E., Durham, S. B. &amp; Virnig, B. A. Risk of pelvic fractures in older women following pelvic irradiation. <italic toggle="yes">JAMA</italic><bold>294</bold>, 2587&#8211;2593 (2005).<pub-id pub-id-type="pmid">16304072</pub-id><pub-id pub-id-type="doi">10.1001/jama.294.20.2587</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>TF</given-names></name><name name-style="western"><surname>Leblanc</surname><given-names>AD</given-names></name><name name-style="western"><surname>Evans</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight</article-title><source>J. Bone Min. Res.</source><year>2006</year><volume>21</volume><fpage>1224</fpage><lpage>1230</lpage><pub-id pub-id-type="doi">10.1359/jbmr.060509</pub-id><pub-id pub-id-type="pmid">16869720</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Lang, T. F., Leblanc, A. D., Evans, H. J. &amp; Lu, Y. Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight. <italic toggle="yes">J. Bone Min. Res.</italic><bold>21</bold>, 1224&#8211;1230 (2006).<pub-id pub-id-type="doi">10.1359/jbmr.060509</pub-id><pub-id pub-id-type="pmid">16869720</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Benefits for bone from resistance exercise and nutrition in long-duration spaceflight: Evidence from biochemistry and densitometry</article-title><source>J. Bone Min. Res.</source><year>2012</year><volume>27</volume><fpage>1896</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1002/jbmr.1647</pub-id><pub-id pub-id-type="pmid">22549960</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Smith, S. M. et al. Benefits for bone from resistance exercise and nutrition in long-duration spaceflight: Evidence from biochemistry and densitometry. <italic toggle="yes">J. Bone Min. Res.</italic><bold>27</bold>, 1896&#8211;1906 (2012).<pub-id pub-id-type="doi">10.1002/jbmr.1647</pub-id><pub-id pub-id-type="pmid">22549960</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>English</surname><given-names>KL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SMC</given-names></name><name name-style="western"><surname>Loehr</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ploutz-Snyder</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Ploutz-Snyder</surname><given-names>LL</given-names></name></person-group><article-title>Isokinetic strength changes following long-duration spaceflight on the ISS</article-title><source>Aerosp. Med. Hum. Perform.</source><year>2015</year><volume>86</volume><fpage>A68</fpage><lpage>A77</lpage><pub-id pub-id-type="doi">10.3357/AMHP.EC09.2015</pub-id><pub-id pub-id-type="pmid">26630197</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">English, K. L., Lee, S. M. C., Loehr, J. A., Ploutz-Snyder, R. J. &amp; Ploutz-Snyder, L. L. Isokinetic strength changes following long-duration spaceflight on the ISS. <italic toggle="yes">Aerosp. Med. Hum. Perform.</italic><bold>86</bold>, A68&#8211;A77 (2015).<pub-id pub-id-type="pmid">26630197</pub-id><pub-id pub-id-type="doi">10.3357/AMHP.EC09.2015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crucian</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Countermeasures-based improvements in stress, immune system dysregulation and latent herpesvirus reactivation onboard the International Space Station - Relevance for deep space missions and terrestrial medicine</article-title><source>Neurosci. Biobehav. Rev.</source><year>2020</year><volume>115</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.05.007</pub-id><pub-id pub-id-type="pmid">32464118</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Crucian, B. E. et al. Countermeasures-based improvements in stress, immune system dysregulation and latent herpesvirus reactivation onboard the International Space Station - Relevance for deep space missions and terrestrial medicine. <italic toggle="yes">Neurosci. Biobehav. Rev.</italic><bold>115</bold>, 68&#8211;76 (2020).<pub-id pub-id-type="pmid">32464118</pub-id><pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.05.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Baca J., et al. Modular multi-motor exercise system for space exploration. <italic toggle="yes">SN Appl. Sci.</italic>10.1007/s42452-020-2315-1 (2020).</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Zwart</surname><given-names>SR</given-names></name><name name-style="western"><surname>Block</surname><given-names>G</given-names></name><name name-style="western"><surname>Rice</surname><given-names>BL</given-names></name><name name-style="western"><surname>Davis-Street</surname><given-names>JE</given-names></name></person-group><article-title>The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station</article-title><source>J. Nutr.</source><year>2005</year><volume>135</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1093/jn/135.3.437</pub-id><pub-id pub-id-type="pmid">15735075</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Smith, S. M., Zwart, S. R., Block, G., Rice, B. L. &amp; Davis-Street, J. E. The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. <italic toggle="yes">J. Nutr.</italic><bold>135</bold>, 437&#8211;443 (2005).<pub-id pub-id-type="pmid">15735075</pub-id><pub-id pub-id-type="doi">10.1093/jn/135.3.437</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Smith, S., Heer, M., Zwart, S. Nutrition and human space flight: Evidence from 4&#8211;6 month missions to the International Space Station. <italic toggle="yes">Curr. Dev. Nutr.</italic> 1146&#8211;1146. (2020).</mixed-citation></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuelke</surname><given-names>M</given-names></name><etal/></person-group><article-title>Myostatin mutation associated with gross muscle hypertrophy in a child</article-title><source>N. Engl. J. Med.</source><year>2004</year><volume>350</volume><fpage>2682</fpage><lpage>2688</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa040933</pub-id><pub-id pub-id-type="pmid">15215484</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Schuelke, M. et al. Myostatin mutation associated with gross muscle hypertrophy in a child. <italic toggle="yes">N. Engl. J. Med.</italic><bold>350</bold>, 2682&#8211;2688 (2004).<pub-id pub-id-type="pmid">15215484</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa040933</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>C</given-names></name><etal/></person-group><article-title>Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial</article-title><source>Lancet Diabetes Endocrinol.</source><year>2015</year><volume>3</volume><fpage>948</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(15)00298-3</pub-id><pub-id pub-id-type="pmid">26516121</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Becker, C. et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. <italic toggle="yes">Lancet Diabetes Endocrinol.</italic><bold>3</bold>, 948&#8211;957 (2015).<pub-id pub-id-type="pmid">26516121</pub-id><pub-id pub-id-type="doi">10.1016/S2213-8587(15)00298-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saremi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of oral creatine and resistance training on serum myostatin and GASP-1</article-title><source>Mol. Cell Endocrinol.</source><year>2010</year><volume>317</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2009.12.019</pub-id><pub-id pub-id-type="pmid">20026378</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Saremi, A. et al. Effects of oral creatine and resistance training on serum myostatin and GASP-1. <italic toggle="yes">Mol. Cell Endocrinol.</italic><bold>317</bold>, 25&#8211;30 (2010).<pub-id pub-id-type="pmid">20026378</pub-id><pub-id pub-id-type="doi">10.1016/j.mce.2009.12.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyden</surname><given-names>LM</given-names></name><etal/></person-group><article-title>High bone density due to a mutation in LDL-receptor&#8211;related Protein 5</article-title><source>N. Engl. J. Med.</source><year>2002</year><volume>346</volume><fpage>1513</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa013444</pub-id><pub-id pub-id-type="pmid">12015390</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Boyden, L. M. et al. High bone density due to a mutation in LDL-receptor&#8211;related Protein 5. <italic toggle="yes">N. Engl. J. Med.</italic><bold>346</bold>, 1513&#8211;1521 (2002).<pub-id pub-id-type="pmid">12015390</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa013444</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxon</surname><given-names>LK</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>BF</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Lanyon</surname><given-names>LE</given-names></name><name name-style="western"><surname>Price</surname><given-names>JS</given-names></name></person-group><article-title>Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it</article-title><source>Bone</source><year>2011</year><volume>49</volume><fpage>184</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2011.03.683</pub-id><pub-id pub-id-type="pmid">21419885</pub-id><pub-id pub-id-type="pmcid">PMC3121951</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Saxon, L. K., Jackson, B. F., Sugiyama, T., Lanyon, L. E. &amp; Price, J. S. Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it. <italic toggle="yes">Bone</italic><bold>49</bold>, 184&#8211;193 (2011).<pub-id pub-id-type="pmid">21419885</pub-id><pub-id pub-id-type="doi">10.1016/j.bone.2011.03.683</pub-id><pub-id pub-id-type="pmcid">PMC3121951</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Chapelle</surname><given-names>A</given-names></name><name name-style="western"><surname>Tr&#228;skelin</surname><given-names>AL</given-names></name><name name-style="western"><surname>Juvonen</surname><given-names>E</given-names></name></person-group><article-title>Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1993</year><volume>90</volume><fpage>4495</fpage><lpage>4499</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.10.4495</pub-id><pub-id pub-id-type="pmid">8506290</pub-id><pub-id pub-id-type="pmcid">PMC46538</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">de la Chapelle, A., Tr&#228;skelin, A. L. &amp; Juvonen, E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>90</bold>, 4495&#8211;4499 (1993).<pub-id pub-id-type="pmid">8506290</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.10.4495</pub-id><pub-id pub-id-type="pmcid">PMC46538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weisgraber</surname><given-names>KH</given-names></name><name name-style="western"><surname>Bersot</surname><given-names>TP</given-names></name><name name-style="western"><surname>Mahley</surname><given-names>RW</given-names></name><name name-style="western"><surname>Franceschini</surname><given-names>G</given-names></name><name name-style="western"><surname>Sirtori</surname><given-names>CR</given-names></name></person-group><article-title>A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins</article-title><source>J. Clin. Invest.</source><year>1980</year><volume>66</volume><fpage>901</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1172/JCI109957</pub-id><pub-id pub-id-type="pmid">6776144</pub-id><pub-id pub-id-type="pmcid">PMC371524</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Weisgraber, K. H., Bersot, T. P., Mahley, R. W., Franceschini, G. &amp; Sirtori, C. R. A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. <italic toggle="yes">J. Clin. Invest.</italic><bold>66</bold>, 901&#8211;907 (1980).<pub-id pub-id-type="pmid">6776144</pub-id><pub-id pub-id-type="doi">10.1172/JCI109957</pub-id><pub-id pub-id-type="pmcid">PMC371524</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualandri</surname><given-names>V</given-names></name><etal/></person-group><article-title>AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission</article-title><source>Am. J. Hum. Genet.</source><year>1985</year><volume>37</volume><fpage>1083</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">3936350</pub-id><pub-id pub-id-type="pmcid">PMC1684746</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Gualandri, V. et al. AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. <italic toggle="yes">Am. J. Hum. Genet.</italic><bold>37</bold>, 1083&#8211;1097 (1985).<pub-id pub-id-type="pmid">3936350</pub-id><pub-id pub-id-type="pmcid">PMC1684746</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Shah, P. K. HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigm. <italic toggle="yes">Future Lipidol</italic>. 55&#8211;64 (2006).</mixed-citation></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hauptmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Mohan</surname><given-names>AK</given-names></name><name name-style="western"><surname>Doody</surname><given-names>MM</given-names></name><name name-style="western"><surname>Linet</surname><given-names>MS</given-names></name><name name-style="western"><surname>Mabuchi</surname><given-names>K</given-names></name></person-group><article-title>Mortality from diseases of the circulatory system in radiologic technologists in the United States</article-title><source>Am. J. Epidemiol.</source><year>2003</year><volume>157</volume><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1093/aje/kwf189</pub-id><pub-id pub-id-type="pmid">12543624</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Hauptmann, M., Mohan, A. K., Doody, M. M., Linet, M. S. &amp; Mabuchi, K. Mortality from diseases of the circulatory system in radiologic technologists in the United States. <italic toggle="yes">Am. J. Epidemiol.</italic><bold>157</bold>, 239&#8211;248 (2003).<pub-id pub-id-type="pmid">12543624</pub-id><pub-id pub-id-type="doi">10.1093/aje/kwf189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name><name name-style="western"><surname>Naito</surname><given-names>K</given-names></name><name name-style="western"><surname>Kasagi</surname><given-names>F</given-names></name><name name-style="western"><surname>Masunari</surname><given-names>N</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>G</given-names></name></person-group><article-title>Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study</article-title><source>Int J. Radiat. Biol.</source><year>2005</year><volume>81</volume><fpage>821</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1080/09553000600555504</pub-id><pub-id pub-id-type="pmid">16484151</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Yamada, M., Naito, K., Kasagi, F., Masunari, N. &amp; Suzuki, G. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study. <italic toggle="yes">Int J. Radiat. Biol.</italic><bold>81</bold>, 821&#8211;826 (2005).<pub-id pub-id-type="pmid">16484151</pub-id><pub-id pub-id-type="doi">10.1080/09553000600555504</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meerman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Myocardial disease and long-distance space travel: solving the radiation problem</article-title><source>Front. Cardiovasc. Med.</source><year>2021</year><volume>8</volume><fpage>631985</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2021.631985</pub-id><pub-id pub-id-type="pmid">33644136</pub-id><pub-id pub-id-type="pmcid">PMC7906998</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Meerman, M. et al. Myocardial disease and long-distance space travel: solving the radiation problem. <italic toggle="yes">Front. Cardiovasc. Med.</italic><bold>8</bold>, 631985 (2021).<pub-id pub-id-type="pmid">33644136</pub-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.631985</pub-id><pub-id pub-id-type="pmcid">PMC7906998</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guevara-Aguirre</surname><given-names>J</given-names></name><etal/></person-group><article-title>Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans</article-title><source>Sci. Transl. Med.</source><year>2011</year><volume>3</volume><fpage>70ra13</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3001845</pub-id><pub-id pub-id-type="pmid">21325617</pub-id><pub-id pub-id-type="pmcid">PMC3357623</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. <italic toggle="yes">Sci. Transl. Med.</italic><bold>3</bold>, 70ra13 (2011).<pub-id pub-id-type="pmid">21325617</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3001845</pub-id><pub-id pub-id-type="pmcid">PMC3357623</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coschigano</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth Factor I levels and increased life span</article-title><source>Endocrinology</source><year>2003</year><volume>144</volume><fpage>3799</fpage><lpage>3810</lpage><pub-id pub-id-type="doi">10.1210/en.2003-0374</pub-id><pub-id pub-id-type="pmid">12933651</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth Factor I levels and increased life span. <italic toggle="yes">Endocrinology</italic><bold>144</bold>, 3799&#8211;3810 (2003).<pub-id pub-id-type="pmid">12933651</pub-id><pub-id pub-id-type="doi">10.1210/en.2003-0374</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulain</surname><given-names>M</given-names></name><etal/></person-group><article-title>Specific features of the oldest old from the Longevity Blue Zones in Ikaria and Sardinia</article-title><source>Mech. Ageing Dev.</source><year>2021</year><volume>198</volume><fpage>111543</fpage><pub-id pub-id-type="doi">10.1016/j.mad.2021.111543</pub-id><pub-id pub-id-type="pmid">34265327</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Poulain, M. et al. Specific features of the oldest old from the Longevity Blue Zones in Ikaria and Sardinia. <italic toggle="yes">Mech. Ageing Dev.</italic><bold>198</bold>, 111543 (2021).<pub-id pub-id-type="pmid">34265327</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2021.111543</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schagatay</surname><given-names>E</given-names></name></person-group><article-title>Human breath-hold diving ability and the underlying physiology</article-title><source>Hum. Evol.</source><year>2014</year><volume>29</volume><fpage>125</fpage><lpage>140</lpage></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Schagatay, E. Human breath-hold diving ability and the underlying physiology. <italic toggle="yes">Hum. Evol.</italic><bold>29</bold>, 125&#8211;140 (2014).</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilardo</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Physiological and genetic adaptations to diving in sea nomads</article-title><source>Cell</source><year>2018</year><volume>173</volume><fpage>569</fpage><lpage>580.e15</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.054</pub-id><pub-id pub-id-type="pmid">29677510</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Ilardo, M. A. et al. Physiological and genetic adaptations to diving in sea nomads. <italic toggle="yes">Cell</italic><bold>173</bold>, 569&#8211;580.e15 (2018).<pub-id pub-id-type="pmid">29677510</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.054</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>V</given-names></name><name name-style="western"><surname>Davis</surname><given-names>DA</given-names></name><name name-style="western"><surname>Haque</surname><given-names>M</given-names></name><name name-style="western"><surname>Eric Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yarchoan</surname><given-names>R</given-names></name></person-group><article-title>Differential gene up-regulation by Hypoxia-Inducible Factor-1&#945; and Hypoxia-Inducible Factor-2&#945; in HEK293T cells</article-title><source>Cancer Res.</source><year>2005</year><volume>65</volume><fpage>3299</fpage><lpage>3306</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-4130</pub-id><pub-id pub-id-type="pmid">15833863</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Wang, V., Davis, D. A., Haque, M., Eric Huang, L. &amp; Yarchoan, R. Differential gene up-regulation by Hypoxia-Inducible Factor-1&#945; and Hypoxia-Inducible Factor-2&#945; in HEK293T cells. <italic toggle="yes">Cancer Res.</italic><bold>65</bold>, 3299&#8211;3306 (2005).<pub-id pub-id-type="pmid">15833863</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-4130</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beall</surname><given-names>CM</given-names></name></person-group><article-title>Two routes to functional adaptation: Tibetan and Andean high-altitude natives</article-title><source>Proc. Natl Acad. Sci. USA.</source><year>2007</year><volume>104</volume><fpage>8655</fpage><lpage>8660</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701985104</pub-id><pub-id pub-id-type="pmid">17494744</pub-id><pub-id pub-id-type="pmcid">PMC1876443</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Beall, C. M. Two routes to functional adaptation: Tibetan and Andean high-altitude natives. <italic toggle="yes">Proc. Natl Acad. Sci. USA.</italic><bold>104</bold>, 8655&#8211;8660 (2007).<pub-id pub-id-type="pmid">17494744</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0701985104</pub-id><pub-id pub-id-type="pmcid">PMC1876443</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genetic signatures of high-altitude adaptation in Tibetans</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>4189</fpage><lpage>4194</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617042114</pub-id><pub-id pub-id-type="pmid">28373541</pub-id><pub-id pub-id-type="pmcid">PMC5402460</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Yang, J. et al. Genetic signatures of high-altitude adaptation in Tibetans. <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>114</bold>, 4189&#8211;4194 (2017).<pub-id pub-id-type="pmid">28373541</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1617042114</pub-id><pub-id pub-id-type="pmcid">PMC5402460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beheshti</surname><given-names>A</given-names></name><name name-style="western"><surname>Cekanaviciute</surname><given-names>E</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Costes</surname><given-names>SV</given-names></name></person-group><article-title>Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>4191</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-22613-1</pub-id><pub-id pub-id-type="pmid">29520055</pub-id><pub-id pub-id-type="pmcid">PMC5843582</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Beheshti, A., Cekanaviciute, E., Smith, D. J. &amp; Costes, S. V. Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study. <italic toggle="yes">Sci. Rep.</italic><bold>8</bold>, 4191 (2018).<pub-id pub-id-type="pmid">29520055</pub-id><pub-id pub-id-type="doi">10.1038/s41598-018-22613-1</pub-id><pub-id pub-id-type="pmcid">PMC5843582</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranciaro</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genetic origins of lactase persistence and the spread of pastoralism in Africa</article-title><source>Am. J. Hum. Genet.</source><year>2014</year><volume>94</volume><fpage>496</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.02.009</pub-id><pub-id pub-id-type="pmid">24630847</pub-id><pub-id pub-id-type="pmcid">PMC3980415</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Ranciaro, A. et al. Genetic origins of lactase persistence and the spread of pastoralism in Africa. <italic toggle="yes">Am. J. Hum. Genet.</italic><bold>94</bold>, 496&#8211;510 (2014).<pub-id pub-id-type="pmid">24630847</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.02.009</pub-id><pub-id pub-id-type="pmcid">PMC3980415</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fumagalli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Greenlandic Inuit show genetic signatures of diet and climate adaptation</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>1343</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1126/science.aab2319</pub-id><pub-id pub-id-type="pmid">26383953</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Fumagalli, M. et al. Greenlandic Inuit show genetic signatures of diet and climate adaptation. <italic toggle="yes">Science</italic><bold>349</bold>, 1343&#8211;1347 (2015).<pub-id pub-id-type="pmid">26383953</pub-id><pub-id pub-id-type="doi">10.1126/science.aab2319</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neeha</surname><given-names>VS</given-names></name><name name-style="western"><surname>Kinth</surname><given-names>P</given-names></name></person-group><article-title>Nutrigenomics research: a review</article-title><source>J. Food Sci. Technol.</source><year>2013</year><volume>50</volume><fpage>415</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1007/s13197-012-0775-z</pub-id><pub-id pub-id-type="pmid">24425937</pub-id><pub-id pub-id-type="pmcid">PMC3602567</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Neeha, V. S. &amp; Kinth, P. Nutrigenomics research: a review. <italic toggle="yes">J. Food Sci. Technol.</italic><bold>50</bold>, 415&#8211;428 (2013).<pub-id pub-id-type="pmid">24425937</pub-id><pub-id pub-id-type="doi">10.1007/s13197-012-0775-z</pub-id><pub-id pub-id-type="pmcid">PMC3602567</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guest</surname><given-names>NS</given-names></name><name name-style="western"><surname>Horne</surname><given-names>J</given-names></name><name name-style="western"><surname>Vanderhout</surname><given-names>SM</given-names></name><name name-style="western"><surname>El-Sohemy</surname><given-names>A</given-names></name></person-group><article-title>Sport nutrigenomics: personalized nutrition for athletic performance</article-title><source>Front. Nutr.</source><year>2019</year><volume>6</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.3389/fnut.2019.00008</pub-id><pub-id pub-id-type="pmid">30838211</pub-id><pub-id pub-id-type="pmcid">PMC6389634</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Guest, N. S., Horne, J., Vanderhout, S. M. &amp; El-Sohemy, A. Sport nutrigenomics: personalized nutrition for athletic performance. <italic toggle="yes">Front. Nutr.</italic><bold>6</bold>, 8 (2019).<pub-id pub-id-type="pmid">30838211</pub-id><pub-id pub-id-type="doi">10.3389/fnut.2019.00008</pub-id><pub-id pub-id-type="pmcid">PMC6389634</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zwart</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes</article-title><source>FASEB J.</source><year>2016</year><volume>30</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1096/fj.15-278457</pub-id><pub-id pub-id-type="pmid">26316272</pub-id><pub-id pub-id-type="pmcid">PMC4684521</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Zwart, S. R. et al. Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes. <italic toggle="yes">FASEB J.</italic><bold>30</bold>, 141&#8211;148 (2016).<pub-id pub-id-type="pmid">26316272</pub-id><pub-id pub-id-type="doi">10.1096/fj.15-278457</pub-id><pub-id pub-id-type="pmcid">PMC4684521</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crucian</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>1437</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.01437</pub-id><pub-id pub-id-type="pmid">30018614</pub-id><pub-id pub-id-type="pmcid">PMC6038331</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Crucian, B. E. et al. Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions. <italic toggle="yes">Front. Immunol.</italic><bold>9</bold>, 1437 (2018).<pub-id pub-id-type="pmid">30018614</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01437</pub-id><pub-id pub-id-type="pmcid">PMC6038331</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><etal/></person-group><article-title>SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B</article-title><source>Cell Metab.</source><year>2007</year><volume>6</volume><fpage>307</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.08.014</pub-id><pub-id pub-id-type="pmid">17908559</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Sun, C. et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. <italic toggle="yes">Cell Metab.</italic><bold>6</bold>, 307&#8211;319 (2007).<pub-id pub-id-type="pmid">17908559</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2007.08.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughson</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Increased postflight carotid artery stiffness and inflight insulin resistance resulting from 6-mo spaceflight in male and female astronauts</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2016</year><volume>310</volume><fpage>H628</fpage><lpage>H638</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00802.2015</pub-id><pub-id pub-id-type="pmid">26747504</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hughson, R. L. et al. Increased postflight carotid artery stiffness and inflight insulin resistance resulting from 6-mo spaceflight in male and female astronauts. <italic toggle="yes">Am. J. Physiol. Heart Circ. Physiol.</italic><bold>310</bold>, H628&#8211;H638 (2016).<pub-id pub-id-type="pmid">26747504</pub-id><pub-id pub-id-type="doi">10.1152/ajpheart.00802.2015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahn</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Ha</surname><given-names>T</given-names></name></person-group><article-title>Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2010</year><volume>298</volume><fpage>C1510</fpage><lpage>C1516</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00369.2009</pub-id><pub-id pub-id-type="pmid">20357182</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Ahn, J., Lee, H., Kim, S. &amp; Ha, T. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. <italic toggle="yes">Am. J. Physiol. Cell Physiol.</italic><bold>298</bold>, C1510&#8211;C1516 (2010).<pub-id pub-id-type="pmid">20357182</pub-id><pub-id pub-id-type="doi">10.1152/ajpcell.00369.2009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shammas</surname><given-names>MA</given-names></name></person-group><article-title>Telomeres, lifestyle, cancer, and aging</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2011</year><volume>14</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e32834121b1</pub-id><pub-id pub-id-type="pmid">21102320</pub-id><pub-id pub-id-type="pmcid">PMC3370421</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Shammas, M. A. Telomeres, lifestyle, cancer, and aging. <italic toggle="yes">Curr. Opin. Clin. Nutr. Metab. Care</italic><bold>14</bold>, 28&#8211;34 (2011). pp.<pub-id pub-id-type="pmid">21102320</pub-id><pub-id pub-id-type="doi">10.1097/MCO.0b013e32834121b1</pub-id><pub-id pub-id-type="pmcid">PMC3370421</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiota</surname><given-names>C</given-names></name><etal/></person-group><article-title>Flavones inhibit LPS-induced Atrogin-1/MAFbx Expression in mouse C2C12 skeletal Myotubes</article-title><source>J. Nutr. Sci. Vitaminol.</source><year>2015</year><volume>61</volume><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.3177/jnsv.61.188</pub-id><pub-id pub-id-type="pmid">26052151</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Shiota, C. et al. Flavones inhibit LPS-induced Atrogin-1/MAFbx Expression in mouse C2C12 skeletal Myotubes. <italic toggle="yes">J. Nutr. Sci. Vitaminol.</italic><bold>61</bold>, 188&#8211;194 (2015).<pub-id pub-id-type="pmid">26052151</pub-id><pub-id pub-id-type="doi">10.3177/jnsv.61.188</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adorni</surname><given-names>MP</given-names></name><name name-style="western"><surname>Zimetti</surname><given-names>F</given-names></name><name name-style="western"><surname>Lupo</surname><given-names>MG</given-names></name><name name-style="western"><surname>Ruscica</surname><given-names>M</given-names></name><name name-style="western"><surname>Ferri</surname><given-names>N</given-names></name></person-group><article-title>Naturally occurring PCSK9 inhibitors</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><fpage>1440</fpage><pub-id pub-id-type="doi">10.3390/nu12051440</pub-id><pub-id pub-id-type="pmid">32429343</pub-id><pub-id pub-id-type="pmcid">PMC7284437</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Adorni, M. P., Zimetti, F., Lupo, M. G., Ruscica, M. &amp; Ferri, N. Naturally occurring PCSK9 inhibitors. <italic toggle="yes">Nutrients</italic><bold>12</bold>, 1440 (2020).<pub-id pub-id-type="pmid">32429343</pub-id><pub-id pub-id-type="doi">10.3390/nu12051440</pub-id><pub-id pub-id-type="pmcid">PMC7284437</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniell</surname><given-names>H</given-names></name><etal/></person-group><article-title>Affordable oral proinsulin bioencapsulated in plant cells regulates blood sugar levels similar to natural insulin</article-title><source>Biomaterials</source><year>2023</year><volume>298</volume><fpage>122142</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2023.122142</pub-id><pub-id pub-id-type="pmid">37148757</pub-id><pub-id pub-id-type="pmcid">PMC10219636</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Daniell, H. et al. Affordable oral proinsulin bioencapsulated in plant cells regulates blood sugar levels similar to natural insulin. <italic toggle="yes">Biomaterials</italic><bold>298</bold>, 122142 (2023).<pub-id pub-id-type="pmid">37148757</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2023.122142</pub-id><pub-id pub-id-type="pmcid">PMC10219636</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortimer</surname><given-names>JC</given-names></name><name name-style="western"><surname>Gilliham</surname><given-names>M</given-names></name></person-group><article-title>SpaceHort: redesigning plants to support space exploration and on-earth sustainability</article-title><source>Curr. Opin. Biotechnol.</source><year>2021</year><volume>73</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2021.08.018</pub-id><pub-id pub-id-type="pmid">34563931</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Mortimer, J. C. &amp; Gilliham, M. SpaceHort: redesigning plants to support space exploration and on-earth sustainability. <italic toggle="yes">Curr. Opin. Biotechnol.</italic><bold>73</bold>, 246&#8211;252 (2021).<pub-id pub-id-type="pmid">34563931</pub-id><pub-id pub-id-type="doi">10.1016/j.copbio.2021.08.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="other">Schmidt, M. A., Schmidt, C. M., Goodwin, T. J. Pharmacogenomics in Spaceflight: A Foundation of Personalized Medicine in Astronauts. (2019).</mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Pathak, Y., dos Santos, M., &amp; Zea, L., (Eds). Handbook of Space Pharmaceuticals. Springer Nature. Cham. 10.1007/978-3-319-50909-9_26-1.</mixed-citation></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilke</surname><given-names>RA</given-names></name><etal/></person-group><article-title>The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin&#8208;induced myopathy</article-title><source>Clin. Pharmacol. Ther.</source><year>2012</year><volume>92</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1038/clpt.2012.57</pub-id><pub-id pub-id-type="pmid">22617227</pub-id><pub-id pub-id-type="pmcid">PMC3384438</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Wilke, R. A. et al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin&#8208;induced myopathy. <italic toggle="yes">Clin. Pharmacol. Ther.</italic><bold>92</bold>, 112&#8211;117 (2012).<pub-id pub-id-type="pmid">22617227</pub-id><pub-id pub-id-type="doi">10.1038/clpt.2012.57</pub-id><pub-id pub-id-type="pmcid">PMC3384438</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chanfreau-Coffinier</surname><given-names>C</given-names></name><name name-style="western"><surname>Hull</surname><given-names>LE</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>JA</given-names></name><name name-style="western"><surname>Tuteja</surname><given-names>S</given-names></name></person-group><article-title>Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among US veterans health administration pharmacy users</article-title><source>JAMA Netw. Open</source><year>2019</year><volume>2</volume><fpage>e195345</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.5345</pub-id><pub-id pub-id-type="pmid">31173123</pub-id><pub-id pub-id-type="pmcid">PMC6563578</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Chanfreau-Coffinier, C., Hull, L. E., Lynch, J. A. &amp; Tuteja, S. Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among US veterans health administration pharmacy users. <italic toggle="yes">JAMA Netw. Open</italic><bold>2</bold>, e195345 (2019).<pub-id pub-id-type="pmid">31173123</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.5345</pub-id><pub-id pub-id-type="pmcid">PMC6563578</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>MA</given-names></name><name name-style="western"><surname>Jones</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mason</surname><given-names>CE</given-names></name></person-group><article-title>Optimizing human performance in extreme environments through precision medicine: From spaceflight to high-performance operations on Earth. Cambridge Prisms: Precision</article-title><source>Medicine</source><year>2023</year><volume>1</volume><fpage>E27</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/pcm.2023.16</pub-id><pub-id pub-id-type="pmcid">PMC10953751</pub-id><pub-id pub-id-type="pmid">38550927</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Schmidt, M. A., Jones, J. A. &amp; Mason, C. E. Optimizing human performance in extreme environments through precision medicine: From spaceflight to high-performance operations on Earth. Cambridge Prisms: Precision. <italic toggle="yes">Medicine</italic><bold>1</bold>, E27 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/pcm.2023.16</pub-id><pub-id pub-id-type="pmcid">PMC10953751</pub-id><pub-id pub-id-type="pmid">38550927</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sven</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Pharmacogenetics: from bench to byte-an update of guidelines</article-title><source>Clin. Pharmacol. Ther.</source><year>2011</year><volume>89</volume><fpage>662</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1038/clpt.2011.34</pub-id><pub-id pub-id-type="pmid">21412232</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Sven, J. J. et al. Pharmacogenetics: from bench to byte-an update of guidelines. <italic toggle="yes">Clin. Pharmacol. Ther.</italic><bold>89</bold>, 662&#8211;673 (2011).<pub-id pub-id-type="pmid">21412232</pub-id><pub-id pub-id-type="doi">10.1038/clpt.2011.34</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rutter</surname><given-names>L</given-names></name><etal/></person-group><article-title>A new era for space life science: International Standards for Space Omics Processing</article-title><source>Patterns</source><year>2020</year><volume>1</volume><fpage>100148</fpage><pub-id pub-id-type="doi">10.1016/j.patter.2020.100148</pub-id><pub-id pub-id-type="pmid">33336201</pub-id><pub-id pub-id-type="pmcid">PMC7733874</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Rutter, L. et al. A new era for space life science: International Standards for Space Omics Processing. <italic toggle="yes">Patterns</italic><bold>1</bold>, 100148 (2020).<pub-id pub-id-type="pmid">33336201</pub-id><pub-id pub-id-type="doi">10.1016/j.patter.2020.100148</pub-id><pub-id pub-id-type="pmcid">PMC7733874</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="other">Rutter, L. et al. Astronaut omics and the impact of space on the human body at scale. <italic toggle="yes">Nat. Commun</italic>. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-47237-0</pub-id><pub-id pub-id-type="pmcid">PMC11166943</pub-id><pub-id pub-id-type="pmid">38862505</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa</article-title><source>Genome Biol.</source><year>2022</year><volume>23</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/s13059-022-02766-z</pub-id><pub-id pub-id-type="pmid">36100952</pub-id><pub-id pub-id-type="pmcid">PMC9472407</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Kim, M. S. et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. <italic toggle="yes">Genome Biol.</italic><bold>23</bold>, 194 (2022).<pub-id pub-id-type="pmid">36100952</pub-id><pub-id pub-id-type="doi">10.1186/s13059-022-02766-z</pub-id><pub-id pub-id-type="pmcid">PMC9472407</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Rare variant contribution to human disease in 281,104 UK Biobank exomes</article-title><source>Nature</source><year>2021</year><volume>597</volume><fpage>527</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03855-y</pub-id><pub-id pub-id-type="pmid">34375979</pub-id><pub-id pub-id-type="pmcid">PMC8458098</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. <italic toggle="yes">Nature</italic><bold>597</bold>, 527&#8211;532 (2021).<pub-id pub-id-type="pmid">34375979</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03855-y</pub-id><pub-id pub-id-type="pmcid">PMC8458098</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>S-C</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>ED</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases</article-title><source>Eur. J. Med. Genet.</source><year>2015</year><volume>58</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2014.10.004</pub-id><pub-id pub-id-type="pmid">25449138</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Liew, S.-C. &amp; Gupta, E. D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. <italic toggle="yes">Eur. J. Med. Genet.</italic><bold>58</bold>, 1&#8211;10 (2015).<pub-id pub-id-type="pmid">25449138</pub-id><pub-id pub-id-type="doi">10.1016/j.ejmg.2014.10.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mason</surname><given-names>CE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>TM</given-names></name></person-group><article-title>Limitations of the human reference genome for personalized genomics</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e40294</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0040294</pub-id><pub-id pub-id-type="pmid">22811759</pub-id><pub-id pub-id-type="pmcid">PMC3394790</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Rosenfeld, J. A., Mason, C. E. &amp; Smith, T. M. Limitations of the human reference genome for personalized genomics. <italic toggle="yes">PLoS One</italic><bold>7</bold>, e40294 (2012).<pub-id pub-id-type="pmid">22811759</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040294</pub-id><pub-id pub-id-type="pmcid">PMC3394790</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tom&#225;s-Loba</surname><given-names>A</given-names></name><etal/></person-group><article-title>Telomerase reverse transcriptase delays aging in cancer-resistant mice</article-title><source>Cell</source><year>2008</year><volume>135</volume><fpage>609</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.09.034</pub-id><pub-id pub-id-type="pmid">19013273</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Tom&#225;s-Loba, A. et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. <italic toggle="yes">Cell</italic><bold>135</bold>, 609&#8211;622 (2008).<pub-id pub-id-type="pmid">19013273</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2008.09.034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>S</given-names></name><etal/></person-group><article-title>Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>5374</fpage><lpage>5379</lpage><pub-id pub-id-type="doi">10.1073/pnas.0501652102</pub-id><pub-id pub-id-type="pmid">15805190</pub-id><pub-id pub-id-type="pmcid">PMC556275</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Rashid, S. et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>102</bold>, 5374&#8211;5379 (2005).<pub-id pub-id-type="pmid">15805190</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0501652102</pub-id><pub-id pub-id-type="pmcid">PMC556275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>AF</given-names></name><etal/></person-group><article-title>PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study</article-title><source>Lancet Diabetes Endocrinol.</source><year>2017</year><volume>5</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(16)30396-5</pub-id><pub-id pub-id-type="pmid">27908689</pub-id><pub-id pub-id-type="pmcid">PMC5266795</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Schmidt, A. F. et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. <italic toggle="yes">Lancet Diabetes Endocrinol.</italic><bold>5</bold>, 97&#8211;105 (2017).<pub-id pub-id-type="pmid">27908689</pub-id><pub-id pub-id-type="doi">10.1016/S2213-8587(16)30396-5</pub-id><pub-id pub-id-type="pmcid">PMC5266795</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Jones, C. J., et al. Molecular and physiologic changes in the SpaceX Inspiration4 civilian crew. <italic toggle="yes">Nature</italic>. 10.1038/s41586-024-07648-x. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07648-x</pub-id><pub-id pub-id-type="pmcid">PMC11357997</pub-id><pub-id pub-id-type="pmid">38862026</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halama</surname><given-names>N</given-names></name><etal/></person-group><article-title>Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by Anti-CCR5 therapy in cancer patients</article-title><source>Cancer Cell</source><year>2016</year><volume>29</volume><fpage>587</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.03.005</pub-id><pub-id pub-id-type="pmid">27070705</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Halama, N. et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by Anti-CCR5 therapy in cancer patients. <italic toggle="yes">Cancer Cell</italic><bold>29</bold>, 587&#8211;601 (2016).<pub-id pub-id-type="pmid">27070705</pub-id><pub-id pub-id-type="doi">10.1016/j.ccell.2016.03.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>H&#252;tter</surname><given-names>G</given-names></name><etal/></person-group><article-title>Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation</article-title><source>N. Engl. J. Med.</source><year>2009</year><volume>360</volume><fpage>692</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0802905</pub-id><pub-id pub-id-type="pmid">19213682</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">H&#252;tter, G. et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. <italic toggle="yes">N. Engl. J. Med.</italic><bold>360</bold>, 692&#8211;698 (2009).<pub-id pub-id-type="pmid">19213682</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa0802905</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>C-S</given-names></name><etal/></person-group><article-title>The CCL5/CCR5 axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching</article-title><source>Cell Physiol. Biochem.</source><year>2018</year><volume>47</volume><fpage>707</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1159/000490024</pub-id><pub-id pub-id-type="pmid">29794461</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Lin, C.-S. et al. The CCL5/CCR5 axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching. <italic toggle="yes">Cell Physiol. Biochem.</italic><bold>47</bold>, 707&#8211;720 (2018).<pub-id pub-id-type="pmid">29794461</pub-id><pub-id pub-id-type="doi">10.1159/000490024</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez-Martinez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)</article-title><source>J. Antimicrob. Chemother.</source><year>2014</year><volume>69</volume><fpage>1903</fpage><lpage>1910</lpage><pub-id pub-id-type="doi">10.1093/jac/dku071</pub-id><pub-id pub-id-type="pmid">24651825</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Perez-Martinez, L. et al. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). <italic toggle="yes">J. Antimicrob. Chemother.</italic><bold>69</bold>, 1903&#8211;1910 (2014).<pub-id pub-id-type="pmid">24651825</pub-id><pub-id pub-id-type="doi">10.1093/jac/dku071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joy</surname><given-names>MT</given-names></name><etal/></person-group><article-title>CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1143</fpage><lpage>1157.e13</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.01.044</pub-id><pub-id pub-id-type="pmid">30794775</pub-id><pub-id pub-id-type="pmcid">PMC7259116</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Joy, M. T. et al. CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury. <italic toggle="yes">Cell</italic><bold>176</bold>, 1143&#8211;1157.e13 (2019).<pub-id pub-id-type="pmid">30794775</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2019.01.044</pub-id><pub-id pub-id-type="pmcid">PMC7259116</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>RS</given-names></name></person-group><article-title>A moving target: the multiple roles of CCR5 in infectious diseases</article-title><source>J. Infect. Dis.</source><year>2008</year><volume>197</volume><fpage>183</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1086/524692</pub-id><pub-id pub-id-type="pmid">18179384</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Klein, R. S. A moving target: the multiple roles of CCR5 in infectious diseases. <italic toggle="yes">J. Infect. Dis.</italic><bold>197</bold>, 183&#8211;186 (2008).<pub-id pub-id-type="pmid">18179384</pub-id><pub-id pub-id-type="doi">10.1086/524692</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodward</surname><given-names>WA</given-names></name><etal/></person-group><article-title>WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells</article-title><source>Proc. Natl Acad. Sci.</source><year>2007</year><volume>104</volume><fpage>618</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1073/pnas.0606599104</pub-id><pub-id pub-id-type="pmid">17202265</pub-id><pub-id pub-id-type="pmcid">PMC1766434</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Woodward, W. A. et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. <italic toggle="yes">Proc. Natl Acad. Sci.</italic><bold>104</bold>, 618&#8211;623 (2007).<pub-id pub-id-type="pmid">17202265</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0606599104</pub-id><pub-id pub-id-type="pmcid">PMC1766434</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group><article-title>&#946;-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells</article-title><source>Med. Oncol.</source><year>2011</year><volume>28</volume><fpage>608</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1007/s12032-010-9476-5</pub-id><pub-id pub-id-type="pmid">20300972</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Liu, X. et al. &#946;-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. <italic toggle="yes">Med. Oncol.</italic><bold>28</bold>, 608&#8211;614 (2011).<pub-id pub-id-type="pmid">20300972</pub-id><pub-id pub-id-type="doi">10.1007/s12032-010-9476-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">Robling, A. G., Castillo, A. B., Turner, C. H. Biomechanical and molecular regulation of bone remodeling. <italic toggle="yes">Ann. Rev. Biomed. Eng.</italic> 455&#8211;498. (2006).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.bioeng.8.061505.095721</pub-id><pub-id pub-id-type="pmid">16834564</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilbrey-Clark</surname><given-names>A</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>K</given-names></name><name name-style="western"><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><article-title>Cell Atlas technologies and insights into tissue architecture</article-title><source>Biochem. J.</source><year>2020</year><volume>477</volume><fpage>1427</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1042/BCJ20190341</pub-id><pub-id pub-id-type="pmid">32339226</pub-id><pub-id pub-id-type="pmcid">PMC7200628</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">Wilbrey-Clark, A., Roberts, K. &amp; Teichmann, S. A. Cell Atlas technologies and insights into tissue architecture. <italic toggle="yes">Biochem. J.</italic><bold>477</bold>, 1427&#8211;1442 (2020).<pub-id pub-id-type="pmid">32339226</pub-id><pub-id pub-id-type="doi">10.1042/BCJ20190341</pub-id><pub-id pub-id-type="pmcid">PMC7200628</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu&#233;guinou</surname><given-names>N</given-names></name><etal/></person-group><article-title>Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth&#8217;s orbit?</article-title><source>J. Leukoc. Biol.</source><year>2009</year><volume>86</volume><fpage>1027</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1189/jlb.0309167</pub-id><pub-id pub-id-type="pmid">19690292</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Gu&#233;guinou, N. et al. Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth&#8217;s orbit? <italic toggle="yes">J. Leukoc. Biol.</italic><bold>86</bold>, 1027&#8211;1038 (2009).<pub-id pub-id-type="pmid">19690292</pub-id><pub-id pub-id-type="doi">10.1189/jlb.0309167</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satoh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH</article-title><source>Cell Metab.</source><year>2013</year><volume>18</volume><fpage>416</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.07.013</pub-id><pub-id pub-id-type="pmid">24011076</pub-id><pub-id pub-id-type="pmcid">PMC3794712</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Satoh, A. et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. <italic toggle="yes">Cell Metab.</italic><bold>18</bold>, 416&#8211;430 (2013).<pub-id pub-id-type="pmid">24011076</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2013.07.013</pub-id><pub-id pub-id-type="pmcid">PMC3794712</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herranz</surname><given-names>D</given-names></name><etal/></person-group><article-title>Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer</article-title><source>Nat. Commun.</source><year>2010</year><volume>1</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1038/ncomms1001</pub-id><pub-id pub-id-type="pmid">20975665</pub-id><pub-id pub-id-type="pmcid">PMC3641391</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Herranz, D. et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. <italic toggle="yes">Nat. Commun.</italic><bold>1</bold>, 3 (2010).<pub-id pub-id-type="pmid">20975665</pub-id><pub-id pub-id-type="doi">10.1038/ncomms1001</pub-id><pub-id pub-id-type="pmcid">PMC3641391</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="other">Mason, C. E. The Next 500 Years: Engineering Life to Reach New Worlds. MIT Press; 2021.</mixed-citation></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savitsky</surname><given-names>K</given-names></name><etal/></person-group><article-title>A single ataxia telangiectasia gene with a product similar to PI-3 kinase</article-title><source>Science</source><year>1995</year><volume>268</volume><fpage>1749</fpage><lpage>1753</lpage><pub-id pub-id-type="doi">10.1126/science.7792600</pub-id><pub-id pub-id-type="pmid">7792600</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. <italic toggle="yes">Science</italic><bold>268</bold>, 1749&#8211;1753 (1995).<pub-id pub-id-type="pmid">7792600</pub-id><pub-id pub-id-type="doi">10.1126/science.7792600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pluth</surname><given-names>JM</given-names></name><etal/></person-group><article-title>DNA double-strand break and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells</article-title><source>DNA Repair</source><year>2008</year><volume>7</volume><fpage>108</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2007.08.004</pub-id><pub-id pub-id-type="pmid">17919995</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Pluth, J. M. et al. DNA double-strand break and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells. <italic toggle="yes">DNA Repair</italic><bold>7</bold>, 108&#8211;118 (2008).<pub-id pub-id-type="pmid">17919995</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2007.08.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>di Masi</surname><given-names>A</given-names></name><name name-style="western"><surname>Antoccia</surname><given-names>A</given-names></name></person-group><article-title>NBS1 heterozygosity and cancer risk</article-title><source>Curr. Genomics</source><year>2008</year><volume>9</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.2174/138920208784533610</pub-id><pub-id pub-id-type="pmid">19452044</pub-id><pub-id pub-id-type="pmcid">PMC2682932</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">di Masi, A. &amp; Antoccia, A. NBS1 heterozygosity and cancer risk. <italic toggle="yes">Curr. Genomics</italic><bold>9</bold>, 275&#8211;281 (2008).<pub-id pub-id-type="pmid">19452044</pub-id><pub-id pub-id-type="doi">10.2174/138920208784533610</pub-id><pub-id pub-id-type="pmcid">PMC2682932</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waltes</surname><given-names>R</given-names></name><etal/></person-group><article-title>Human RAD50 deficiency in a Nijmegen Breakage Syndrome-like disorder</article-title><source>Am. J. Hum. Genet.</source><year>2009</year><volume>84</volume><fpage>605</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2009.04.010</pub-id><pub-id pub-id-type="pmid">19409520</pub-id><pub-id pub-id-type="pmcid">PMC2681000</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Waltes, R. et al. Human RAD50 deficiency in a Nijmegen Breakage Syndrome-like disorder. <italic toggle="yes">Am. J. Hum. Genet.</italic><bold>84</bold>, 605&#8211;616 (2009).<pub-id pub-id-type="pmid">19409520</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2009.04.010</pub-id><pub-id pub-id-type="pmcid">PMC2681000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Worgul</surname><given-names>B</given-names></name><name name-style="western"><surname>Smilenov</surname><given-names>L</given-names></name></person-group><article-title>Genetic susceptibility to radiation</article-title><source>Adv. Space Res.</source><year>2005</year><volume>35</volume><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.asr.2004.12.032</pub-id><pub-id pub-id-type="pmid">15934202</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Hall, E. J., Brenner, D. J., Worgul, B. &amp; Smilenov, L. Genetic susceptibility to radiation. <italic toggle="yes">Adv. Space Res.</italic><bold>35</bold>, 249&#8211;253 (2005). pp.<pub-id pub-id-type="pmid">15934202</pub-id><pub-id pub-id-type="doi">10.1016/j.asr.2004.12.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komarova</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>3265</fpage><lpage>3271</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207494</pub-id><pub-id pub-id-type="pmid">15064735</pub-id></element-citation><mixed-citation id="mc-CR111" publication-type="journal">Komarova, E. A. et al. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. <italic toggle="yes">Oncogene</italic><bold>23</bold>, 3265&#8211;3271 (2004).<pub-id pub-id-type="pmid">15064735</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1207494</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romeo</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease</article-title><source>Nat. Genet</source><year>2008</year><volume>40</volume><fpage>1461</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1038/ng.257</pub-id><pub-id pub-id-type="pmid">18820647</pub-id><pub-id pub-id-type="pmcid">PMC2597056</pub-id></element-citation><mixed-citation id="mc-CR112" publication-type="journal">Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. <italic toggle="yes">Nat. Genet</italic><bold>40</bold>, 1461&#8211;1465 (2008).<pub-id pub-id-type="pmid">18820647</pub-id><pub-id pub-id-type="doi">10.1038/ng.257</pub-id><pub-id pub-id-type="pmcid">PMC2597056</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abul-Husn</surname><given-names>NS</given-names></name><etal/></person-group><article-title>A protein-truncating HSD17B13 variant and protection from chronic liver disease</article-title><source>N. Engl. J. Med</source><year>2018</year><volume>378</volume><fpage>1096</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1712191</pub-id><pub-id pub-id-type="pmid">29562163</pub-id><pub-id pub-id-type="pmcid">PMC6668033</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Abul-Husn, N. S. et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. <italic toggle="yes">N. Engl. J. Med</italic><bold>378</bold>, 1096&#8211;1106 (2018).<pub-id pub-id-type="pmid">29562163</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa1712191</pub-id><pub-id pub-id-type="pmcid">PMC6668033</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beheshti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>19195</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-55869-2</pub-id><pub-id pub-id-type="pmid">31844325</pub-id><pub-id pub-id-type="pmcid">PMC6915713</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Beheshti, A. et al. Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 19195 (2019).<pub-id pub-id-type="pmid">31844325</pub-id><pub-id pub-id-type="doi">10.1038/s41598-019-55869-2</pub-id><pub-id pub-id-type="pmcid">PMC6915713</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Silveira</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1185</fpage><lpage>1201.e20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.002</pub-id><pub-id pub-id-type="pmid">33242417</pub-id><pub-id pub-id-type="pmcid">PMC7870178</pub-id></element-citation><mixed-citation id="mc-CR115" publication-type="journal">da Silveira, W. A. et al. Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact. <italic toggle="yes">Cell</italic><bold>183</bold>, 1185&#8211;1201.e20 (2020).<pub-id pub-id-type="pmid">33242417</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.002</pub-id><pub-id pub-id-type="pmcid">PMC7870178</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>HR</given-names></name><name name-style="western"><surname>Varma</surname><given-names>A</given-names></name><name name-style="western"><surname>Flowers</surname><given-names>SA</given-names></name><name name-style="western"><surname>Rebeck</surname><given-names>GW</given-names></name></person-group><article-title>Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer&#8217;s disease risk factor APOE</article-title><source>Cancers</source><year>2020</year><volume>12</volume><fpage>3842</fpage><pub-id pub-id-type="doi">10.3390/cancers12123842</pub-id><pub-id pub-id-type="pmid">33352780</pub-id><pub-id pub-id-type="pmcid">PMC7766535</pub-id></element-citation><mixed-citation id="mc-CR116" publication-type="journal">Fernandez, H. R., Varma, A., Flowers, S. A. &amp; Rebeck, G. W. Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer&#8217;s disease risk factor APOE. <italic toggle="yes">Cancers</italic><bold>12</bold>, 3842 (2020).<pub-id pub-id-type="pmid">33352780</pub-id><pub-id pub-id-type="doi">10.3390/cancers12123842</pub-id><pub-id pub-id-type="pmcid">PMC7766535</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahles</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: The impact of APOE and smoking</article-title><source>Psycho-Oncol.</source><year>2014</year><volume>23</volume><fpage>1382</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1002/pon.3545</pub-id><pub-id pub-id-type="pmcid">PMC4214914</pub-id><pub-id pub-id-type="pmid">24789331</pub-id></element-citation><mixed-citation id="mc-CR117" publication-type="journal">Ahles, T. A. et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: The impact of APOE and smoking. <italic toggle="yes">Psycho-Oncol.</italic><bold>23</bold>, 1382&#8211;1390 (2014).<pub-id pub-id-type="doi">10.1002/pon.3545</pub-id><pub-id pub-id-type="pmcid">PMC4214914</pub-id><pub-id pub-id-type="pmid">24789331</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandelblatt</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living</article-title><source>Cancer Study J. Clin. Oncol.</source><year>2018</year><volume>36</volume><fpage>3211</fpage><lpage>3222</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.18.00140</pub-id><pub-id pub-id-type="pmcid">PMC7237199</pub-id><pub-id pub-id-type="pmid">30281396</pub-id></element-citation><mixed-citation id="mc-CR118" publication-type="journal">Mandelblatt, J. S. et al. Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living. <italic toggle="yes">Cancer Study J. Clin. Oncol.</italic><bold>36</bold>, 3211&#8211;3222 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.18.00140</pub-id><pub-id pub-id-type="pmcid">PMC7237199</pub-id><pub-id pub-id-type="pmid">30281396</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="other">Cramer, C. K. et al. Treatment of radiation-induced cognitive decline in adult brain tumor patients. <italic toggle="yes">Curr. Treat. Options Oncol</italic>. (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11864-019-0641-6</pub-id><pub-id pub-id-type="pmcid">PMC6594685</pub-id><pub-id pub-id-type="pmid">30963289</pub-id></mixed-citation></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makale</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumors</article-title><source>Nat. Rev. Neurol.</source><year>2017</year><volume>133</volume><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.185</pub-id><pub-id pub-id-type="pmcid">PMC5805381</pub-id><pub-id pub-id-type="pmid">27982041</pub-id></element-citation><mixed-citation id="mc-CR120" publication-type="journal">Makale, M. T. et al. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumors. <italic toggle="yes">Nat. Rev. Neurol.</italic><bold>133</bold>, 52&#8211;64 (2017).<pub-id pub-id-type="doi">10.1038/nrneurol.2016.185</pub-id><pub-id pub-id-type="pmcid">PMC5805381</pub-id><pub-id pub-id-type="pmid">27982041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosendaal</surname><given-names>FR</given-names></name><name name-style="western"><surname>Koster</surname><given-names>T</given-names></name><name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></name><name name-style="western"><surname>Reitsma</surname><given-names>PH</given-names></name></person-group><article-title>High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)</article-title><source>Blood</source><year>1995</year><volume>85</volume><fpage>1504</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1182/blood.V85.6.1504.bloodjournal8561504</pub-id><pub-id pub-id-type="pmid">7888671</pub-id></element-citation><mixed-citation id="mc-CR121" publication-type="journal">Rosendaal, F. R., Koster, T., Vandenbroucke, J. P. &amp; Reitsma, P. H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). <italic toggle="yes">Blood</italic><bold>85</bold>, 1504&#8211;1508 (1995).<pub-id pub-id-type="pmid">7888671</pub-id><pub-id pub-id-type="doi">10.1182/blood.V85.6.1504.bloodjournal8561504</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cannegieter</surname><given-names>SC</given-names></name><name name-style="western"><surname>Doggen</surname><given-names>CJM</given-names></name><name name-style="western"><surname>van Houwelingen</surname><given-names>HC</given-names></name><name name-style="western"><surname>Rosendaal</surname><given-names>FR</given-names></name></person-group><article-title>Travel-related venous thrombosis: results from a large population-based case control study (MEGA study)</article-title><source>PLoS Med.</source><year>2006</year><volume>3</volume><fpage>e307</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0030307</pub-id><pub-id pub-id-type="pmid">16933962</pub-id><pub-id pub-id-type="pmcid">PMC1551914</pub-id></element-citation><mixed-citation id="mc-CR122" publication-type="journal">Cannegieter, S. C., Doggen, C. J. M., van Houwelingen, H. C. &amp; Rosendaal, F. R. Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). <italic toggle="yes">PLoS Med.</italic><bold>3</bold>, e307 (2006).<pub-id pub-id-type="pmid">16933962</pub-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0030307</pub-id><pub-id pub-id-type="pmcid">PMC1551914</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>V</given-names></name><name name-style="western"><surname>Wotring</surname><given-names>VE</given-names></name></person-group><article-title>Medically induced amenorrhea in female astronauts</article-title><source>NPJ Microgravity</source><year>2016</year><volume>2</volume><fpage>16008</fpage><pub-id pub-id-type="doi">10.1038/npjmgrav.2016.8</pub-id><pub-id pub-id-type="pmid">28725726</pub-id><pub-id pub-id-type="pmcid">PMC5516549</pub-id></element-citation><mixed-citation id="mc-CR123" publication-type="journal">Jain, V. &amp; Wotring, V. E. Medically induced amenorrhea in female astronauts. <italic toggle="yes">NPJ Microgravity</italic><bold>2</bold>, 16008 (2016).<pub-id pub-id-type="pmid">28725726</pub-id><pub-id pub-id-type="doi">10.1038/npjmgrav.2016.8</pub-id><pub-id pub-id-type="pmcid">PMC5516549</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Broderick</surname><given-names>C</given-names></name><name name-style="western"><surname>Hopewell</surname><given-names>S</given-names></name><name name-style="western"><surname>Juszczak</surname><given-names>E</given-names></name><name name-style="western"><surname>Eisinga</surname><given-names>A</given-names></name></person-group><article-title>Compression stockings for preventing deep vein thrombosis in airline passengers</article-title><source>Cochrane Database Syst. Rev.</source><year>2021</year><volume>4</volume><fpage>CD004002</fpage><pub-id pub-id-type="pmid">33878207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD004002.pub4</pub-id><pub-id pub-id-type="pmcid">PMC8092568</pub-id></element-citation><mixed-citation id="mc-CR124" publication-type="journal">Clarke, M. J., Broderick, C., Hopewell, S., Juszczak, E. &amp; Eisinga, A. Compression stockings for preventing deep vein thrombosis in airline passengers. <italic toggle="yes">Cochrane Database Syst. Rev.</italic><bold>4</bold>, CD004002 (2021).<pub-id pub-id-type="pmid">33878207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD004002.pub4</pub-id><pub-id pub-id-type="pmcid">PMC8092568</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griko</surname><given-names>YV</given-names></name><name name-style="western"><surname>Loftus</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Stolc</surname><given-names>V</given-names></name><name name-style="western"><surname>Peletskaya</surname><given-names>E</given-names></name></person-group><article-title>Private spaceflight: a new landscape for dealing with medical risk</article-title><source>Life Sci. Space Res.</source><year>2022</year><volume>33</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.lssr.2022.03.001</pub-id><pub-id pub-id-type="pmid">35491028</pub-id></element-citation><mixed-citation id="mc-CR125" publication-type="journal">Griko, Y. V., Loftus, D. J., Stolc, V. &amp; Peletskaya, E. Private spaceflight: a new landscape for dealing with medical risk. <italic toggle="yes">Life Sci. Space Res.</italic><bold>33</bold>, 41&#8211;47 (2022).<pub-id pub-id-type="doi">10.1016/j.lssr.2022.03.001</pub-id><pub-id pub-id-type="pmid">35491028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="other">Seylani, A. et al. Ethical considerations for the age of non-governmental space exploration. <italic toggle="yes">Nat. Commun.</italic> In press. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-44357-x</pub-id><pub-id pub-id-type="pmcid">PMC11166968</pub-id><pub-id pub-id-type="pmid">38862473</pub-id></mixed-citation></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>S</given-names></name><etal/></person-group><article-title>GeneLab: Omics database for spaceflight experiments</article-title><source>Bioinformatics</source><year>2019</year><volume>35</volume><fpage>1753</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty884</pub-id><pub-id pub-id-type="pmid">30329036</pub-id></element-citation><mixed-citation id="mc-CR127" publication-type="journal">Ray, S. et al. GeneLab: Omics database for spaceflight experiments. <italic toggle="yes">Bioinformatics</italic><bold>35</bold>, 1753&#8211;1759 (2019).<pub-id pub-id-type="pmid">30329036</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bty884</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urquieta</surname><given-names>E</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Hury</surname><given-names>J</given-names></name><name name-style="western"><surname>Donoviel</surname><given-names>D</given-names></name></person-group><article-title>Establishment of an open biomedical database for commercial spaceflight</article-title><source>Nat. Med.</source><year>2022</year><volume>28</volume><fpage>611</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01761-y</pub-id><pub-id pub-id-type="pmid">35318465</pub-id></element-citation><mixed-citation id="mc-CR128" publication-type="journal">Urquieta, E., Wu, J., Hury, J. &amp; Donoviel, D. Establishment of an open biomedical database for commercial spaceflight. <italic toggle="yes">Nat. Med.</italic><bold>28</bold>, 611&#8211;612 (2022).<pub-id pub-id-type="pmid">35318465</pub-id><pub-id pub-id-type="doi">10.1038/s41591-022-01761-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mega</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis</article-title><source>JAMA</source><year>2010</year><volume>304</volume><fpage>1821</fpage><lpage>1830</lpage><pub-id pub-id-type="doi">10.1001/jama.2010.1543</pub-id><pub-id pub-id-type="pmid">20978260</pub-id><pub-id pub-id-type="pmcid">PMC3048820</pub-id></element-citation><mixed-citation id="mc-CR129" publication-type="journal">Mega, J. L. et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. <italic toggle="yes">JAMA</italic><bold>304</bold>, 1821&#8211;1830 (2010).<pub-id pub-id-type="pmid">20978260</pub-id><pub-id pub-id-type="doi">10.1001/jama.2010.1543</pub-id><pub-id pub-id-type="pmcid">PMC3048820</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><citation-alternatives><element-citation id="ec-CR130" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapman</surname><given-names>PB</given-names></name><etal/></person-group><article-title>Improved survival with vemurafenib in melanoma with BRAF V600E mutation</article-title><source>N. Engl. J. Med.</source><year>2011</year><volume>364</volume><fpage>2507</fpage><lpage>2516</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1103782</pub-id><pub-id pub-id-type="pmid">21639808</pub-id><pub-id pub-id-type="pmcid">PMC3549296</pub-id></element-citation><mixed-citation id="mc-CR130" publication-type="journal">Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. <italic toggle="yes">N. Engl. J. Med.</italic><bold>364</bold>, 2507&#8211;2516 (2011).<pub-id pub-id-type="pmid">21639808</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa1103782</pub-id><pub-id pub-id-type="pmcid">PMC3549296</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cope</surname><given-names>H</given-names></name><etal/></person-group><article-title>A data collection programme for improving healthcare in UK human spaceflight ventures</article-title><source>J. Br. Interplanet. Soc.</source><year>2023</year><volume>76</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.59332/jbis-076-06-0213</pub-id></element-citation><mixed-citation id="mc-CR131" publication-type="journal">Cope, H. et al. A data collection programme for improving healthcare in UK human spaceflight ventures. <italic toggle="yes">J. Br. Interplanet. Soc.</italic><bold>76</bold>, 213&#8211;220 (2023).<pub-id pub-id-type="doi">10.59332/jbis-076-06-0213</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frangoul</surname><given-names>H</given-names></name><etal/></person-group><article-title>CRISPR-Cas9 gene editing for sickle cell disease and &#946;-Thalassemia</article-title><source>N. Engl. J. Med.</source><year>2021</year><volume>384</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2031054</pub-id><pub-id pub-id-type="pmid">33283989</pub-id></element-citation><mixed-citation id="mc-CR132" publication-type="journal">Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and &#946;-Thalassemia. <italic toggle="yes">N. Engl. J. Med.</italic><bold>384</bold>, 252&#8211;260 (2021).<pub-id pub-id-type="pmid">33283989</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa2031054</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szocik</surname><given-names>K</given-names></name><etal/></person-group><article-title>Future space missions and human enhancement: Medical and ethical challenges</article-title><source>Futures</source><year>2021</year><volume>133</volume><fpage>102819</fpage><pub-id pub-id-type="doi">10.1016/j.futures.2021.102819</pub-id></element-citation><mixed-citation id="mc-CR133" publication-type="journal">Szocik, K. et al. Future space missions and human enhancement: Medical and ethical challenges. <italic toggle="yes">Futures</italic><bold>133</bold>, 102819 (2021).<pub-id pub-id-type="doi">10.1016/j.futures.2021.102819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><citation-alternatives><element-citation id="ec-CR134" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knoppers</surname><given-names>BM</given-names></name><name name-style="western"><surname>Thorogood</surname><given-names>AM</given-names></name></person-group><article-title>Ethics and big data in health</article-title><source>Curr. Opin. Syst. Biol.</source><year>2017</year><volume>4</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.coisb.2017.07.001</pub-id></element-citation><mixed-citation id="mc-CR134" publication-type="journal">Knoppers, B. M. &amp; Thorogood, A. M. Ethics and big data in health. <italic toggle="yes">Curr. Opin. Syst. Biol.</italic><bold>4</bold>, 53&#8211;57 (2017).<pub-id pub-id-type="doi">10.1016/j.coisb.2017.07.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR135"><label>135.</label><mixed-citation publication-type="other">Winglee, R. Advances in magnetized plasma propulsion and radiation shielding. Proceedings. 2004 NASA/DoD Conference on Evolvable Hardware. 10.1109/eh.2004.1310849 (2004).</mixed-citation></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hargens</surname><given-names>AR</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>R</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>SM</given-names></name></person-group><article-title>Space physiology VI: exercise, artificial gravity, and countermeasure development for prolonged space flight</article-title><source>Eur. J. Appl. Physiol.</source><year>2013</year><volume>113</volume><fpage>2183</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1007/s00421-012-2523-5</pub-id><pub-id pub-id-type="pmid">23079865</pub-id></element-citation><mixed-citation id="mc-CR136" publication-type="journal">Hargens, A. R., Bhattacharya, R. &amp; Schneider, S. M. Space physiology VI: exercise, artificial gravity, and countermeasure development for prolonged space flight. <italic toggle="yes">Eur. J. Appl. Physiol.</italic><bold>113</bold>, 2183&#8211;2192 (2013).<pub-id pub-id-type="pmid">23079865</pub-id><pub-id pub-id-type="doi">10.1007/s00421-012-2523-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nangle</surname><given-names>SN</given-names></name><etal/></person-group><article-title>The case for biotech on Mars</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0485-4</pub-id><pub-id pub-id-type="pmid">32265561</pub-id></element-citation><mixed-citation id="mc-CR137" publication-type="journal">Nangle, S. N. et al. The case for biotech on Mars. <italic toggle="yes">Nat. Biotechnol.</italic><bold>38</bold>, 401&#8211;407 (2020).<pub-id pub-id-type="pmid">32265561</pub-id><pub-id pub-id-type="doi">10.1038/s41587-020-0485-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="other">Church, C. Protective alleles. [cited 21 Aug 2023]. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://arep.med.harvard.edu/gmc/protect.html">https://arep.med.harvard.edu/gmc/protect.html</ext-link></mixed-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="other">Overbey, E. G., et al. The Space Omics and Medical Atlas (SOMA) and international astronaut biobank. <italic toggle="yes">Nature</italic>10.1038/s41586-024-07639-y (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07639-y</pub-id><pub-id pub-id-type="pmcid">PMC11357981</pub-id><pub-id pub-id-type="pmid">38862028</pub-id></mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="other">Mason, C. E., et al. A second space age spanning omics, platforms, and medicine across orbits. <italic toggle="yes">Nature</italic>10.1038/s41586-024-07586-8 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07586-8</pub-id><pub-id pub-id-type="pmcid">PMC12366838</pub-id><pub-id pub-id-type="pmid">38862027</pub-id></mixed-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="other">Kim, J., et al. Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight. <italic toggle="yes">Nat. Commun</italic>. 10.1038/s41467-024-49211-2. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-49211-2</pub-id><pub-id pub-id-type="pmcid">PMC11166952</pub-id><pub-id pub-id-type="pmid">38862516</pub-id></mixed-citation></ref><ref id="CR142"><label>142.</label><mixed-citation publication-type="other">Tierney, B., et al. Longitudinal multi-omics analysis of host microbiome architecture and immune responses during short-term spaceflight. <italic toggle="yes">Nat. Microbiol</italic>. 10.1038/s41564-024-01635-8. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41564-024-01635-8</pub-id><pub-id pub-id-type="pmcid">PMC11222149</pub-id><pub-id pub-id-type="pmid">38862604</pub-id></mixed-citation></ref><ref id="CR143"><label>143.</label><mixed-citation publication-type="other">Park J., et al. Spatial multi-omics of human skin reveals KRAS and inflammatory responses to spaceflight. <italic toggle="yes">Nat. Commun</italic>. 10.1038/s41467-024-48625-2. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48625-2</pub-id><pub-id pub-id-type="pmcid">PMC11166909</pub-id><pub-id pub-id-type="pmid">38862494</pub-id></mixed-citation></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="other">Overbey, E. G., et al. Collection of biospecimens from the Inspiration4 Mission establishes the standards for the Space Omics and Medical Atlas (SOMA). <italic toggle="yes">Nat. Commun</italic>. 10.1038/s41467-024-48806-z. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48806-z</pub-id><pub-id pub-id-type="pmcid">PMC11166662</pub-id><pub-id pub-id-type="pmid">38862509</pub-id></mixed-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="other">Houerbi, N., et al. Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflight. <italic toggle="yes">Nat. Commun</italic>. 10.1038/s41467-024-48841-w. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48841-w</pub-id><pub-id pub-id-type="pmcid">PMC11166969</pub-id><pub-id pub-id-type="pmid">38862464</pub-id></mixed-citation></ref><ref id="CR146"><label>146.</label><mixed-citation publication-type="other">Grigorev, K. et al. Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and hematopoietic transcriptional responses. <italic toggle="yes">Nat. Commun</italic>. 10.1038/s41467-024-48929-3. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48929-3</pub-id><pub-id pub-id-type="pmcid">PMC11166648</pub-id><pub-id pub-id-type="pmid">38862496</pub-id></mixed-citation></ref><ref id="CR147"><label>147.</label><mixed-citation publication-type="other">Garcia Medina, S. Genome and Clonal Hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes to short duration spaceflight. <italic toggle="yes">Precis. Clin. Med</italic>. In press. 10.1093/pcmedi/pbae007. (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pcmedi/pbae007</pub-id><pub-id pub-id-type="pmcid">PMC11022651</pub-id><pub-id pub-id-type="pmid">38634106</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>